<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <meta name="author" content="hbaolong@vip.qq.com" />
  <title>癌症传EN:Photograph Credits</title>
  <style>
    html {
      color: #1a1a1a;
      background-color: #fdfdfd;
    }
    body {
      margin: 0 auto;
      max-width: 36em;
      padding-left: 50px;
      padding-right: 50px;
      padding-top: 50px;
      padding-bottom: 50px;
      hyphens: auto;
      overflow-wrap: break-word;
      text-rendering: optimizeLegibility;
      font-kerning: normal;
    }
    @media (max-width: 600px) {
      body {
        font-size: 0.9em;
        padding: 12px;
      }
      h1 {
        font-size: 1.8em;
      }
    }
    @media print {
      html {
        background-color: white;
      }
      body {
        background-color: transparent;
        color: black;
        font-size: 12pt;
      }
      p, h2, h3 {
        orphans: 3;
        widows: 3;
      }
      h2, h3, h4 {
        page-break-after: avoid;
      }
    }
    p {
      margin: 1em 0;
    }
    a {
      color: #1a1a1a;
    }
    a:visited {
      color: #1a1a1a;
    }
    img {
      max-width: 100%;
    }
    svg {
      height: auto;
      max-width: 100%;
    }
    h1, h2, h3, h4, h5, h6 {
      margin-top: 1.4em;
    }
    h5, h6 {
      font-size: 1em;
      font-style: italic;
    }
    h6 {
      font-weight: normal;
    }
    ol, ul {
      padding-left: 1.7em;
      margin-top: 1em;
    }
    li > ol, li > ul {
      margin-top: 0;
    }
    blockquote {
      margin: 1em 0 1em 1.7em;
      padding-left: 1em;
      border-left: 2px solid #e6e6e6;
      color: #606060;
    }
    code {
      font-family: Menlo, Monaco, Consolas, 'Lucida Console', monospace;
      font-size: 85%;
      margin: 0;
      hyphens: manual;
    }
    pre {
      margin: 1em 0;
      overflow: auto;
    }
    pre code {
      padding: 0;
      overflow: visible;
      overflow-wrap: normal;
    }
    .sourceCode {
     background-color: transparent;
     overflow: visible;
    }
    hr {
      background-color: #1a1a1a;
      border: none;
      height: 1px;
      margin: 1em 0;
    }
    table {
      margin: 1em 0;
      border-collapse: collapse;
      width: 100%;
      overflow-x: auto;
      display: block;
      font-variant-numeric: lining-nums tabular-nums;
    }
    table caption {
      margin-bottom: 0.75em;
    }
    tbody {
      margin-top: 0.5em;
      border-top: 1px solid #1a1a1a;
      border-bottom: 1px solid #1a1a1a;
    }
    th {
      border-top: 1px solid #1a1a1a;
      padding: 0.25em 0.5em 0.25em 0.5em;
    }
    td {
      padding: 0.125em 0.5em 0.25em 0.5em;
    }
    header {
      margin-bottom: 4em;
      text-align: center;
    }
    #TOC li {
      list-style: none;
    }
    #TOC ul {
      padding-left: 1.3em;
    }
    #TOC > ul {
      padding-left: 0;
    }
    #TOC a:not(:hover) {
      text-decoration: none;
    }
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    /* The extra [class] is a hack that increases specificity enough to
       override a similar rule in reveal.js */
    ul.task-list[class]{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      font-size: inherit;
      width: 0.8em;
      margin: 0 0.8em 0.2em -1.6em;
      vertical-align: middle;
    }
    .display.math{display: block; text-align: center; margin: 0.5rem auto;}
  </style>
</head>
<body>
<header id="title-block-header">
<h1 class="title">癌症传EN:Photograph Credits</h1>
<p class="author">hbaolong@vip.qq.com</p>
</header>
<center>
<a href="/3place/azzen">返回首页</a> <a
href="/3place/azzen/mingju.html">本书名句</a> <a
href="/3place/azzen/memo.html">本书注解</a> <a
href="/3place/azzen/index_rich.html">丰富目录</a> <a
href="/3place/azzen/index_readcal.html">同读日历</a> <a
href="/3place/azzen/index_timeline.html">时间线</a> <a
href="/3place/azzen/index_books.html">引用书籍</a> <a
href="/3place/azzen/index_words.html">使用字频</a>
<div id="wx_pic" style="margin:0 auto;display:none;">
<img src='/img/logo.png'/>
</div>
</center>
<h4 id="photograph-credits">Photograph Credits</h4>
<p>Page 1 (top left to bottom): The New York Academy of Medicine; Public
Domain; Public Domain. Page 2: The Alan Mason Chesney Medical Archives,
the Johns Hopkins Medical Institutions (three images). Page 3: Photo
from Laboratoire Curie, Institut de Physique Nucléaire; courtesy of AIP
Emilio Segrè Visual Archives; © Keystone/Getty Images; Boston Herald.
Page 4: Courtesy of the Albert and Mary Lasker Foundation; the Jimmy
Fund; Courtesy of the Brearley Collection. Page 5: National Cancer
Institute/Public Domain; National Cancer Institute/Public Domain;
National Library of Medicine/Public Domain. Page 6: Courtesy of the
Albert and Mary Lasker Foundation/Public Domain; 1971 Herblock cartoon ©
by the Herb Block Foundation; © Hugo Villalobos/AFP/Newscom.com. Page 7:
© Roger Viollet/The Image Works; Corbis (two images); Associated Press.
Page 8: Cold Spring Harbor Laboratory Archives; © and courtesy of
Dr. Robert A. Weinberg, Whitehead Institute; © Bert Vogelstein.
Reprinted with permission from Science 318, no. 5853 (2007): 1108–1113,
“The Genomic Landscapes of Human Breast and Colorectal Cancers,” © AAAS;
Dean Bradfield.</p>
<p>Page xv: Swimming Crab illustration © 19th era 2/Alamy</p>
<p>Index</p>
<p>Abbott, Edward, 56</p>
<p>abl gene, 431, 433</p>
<p>ABMTs, see bone marrow transplants, autologous</p>
<p>ABO regimen, 204</p>
<p>abortion, 199</p>
<p>Achilles, 405</p>
<p>Actinomyces, 122</p>
<p>actinomycin D, 122–23, 162–63</p>
<p>ACT UP, 318–19, 322, 424</p>
<p>acute lymphoblastic leukemia (ALL), 3, 7, 34, 93, 164, 166, 228,
452</p>
<p>brain as “sanctuary” for, 127, 442</p>
<p>cure rate for, 7, 12, 104, 170, 171, 228, 231, 232, 401</p>
<p>remissions of, 127, 190, 338–39, 400, 448–49</p>
<p>research consortium for, 130–31, 133, 144</p>
<p>6-MP and, 92, 338</p>
<p>acute promyelocytic leukemia (APL), 407–10</p>
<p>Adams, Jim, 113</p>
<p>adenoma, 385</p>
<p>Adriamycin, 127, 206, 427–28</p>
<p>affluent society, 23</p>
<p>Africa, sub-Saharan, 175</p>
<p>age, cancer as related to, 6, 44, 230, 300–303</p>
<p>age-adjusting, of mortality rates, 230–31, 232–33, 330</p>
<p>AIDS (acquired immunodeficiency syndrome), 182</p>
<p>as metaphor for social and political ills, 316</p>
<p>naming of, 14</p>
<p>1980s epidemic of, 165, 315–19</p>
<p>oncologists and, 316–17</p>
<p>stigmatization of, 316</p>
<p>see also HIV</p>
<p>AIDS activists:</p>
<p>access to experimental therapies demanded by, 319, 322, 424</p>
<p>public campaign of, 318–19</p>
<p>Akhmatova, Anna, 461</p>
<p>ALGB, 130–31, 133, 144</p>
<p>alizarin, 82</p>
<p>ALL, see acute lymphoblastic leukemia</p>
<p>Allen, Woody, 384</p>
<p>Allgemeines Krankenhaus, 58–59, 62</p>
<p>All’s Well That Ends Well (Shakespeare), 191</p>
<p>Alsop, Stewart, 202–3, 206</p>
<p>American Association for Cancer Research, 24–25</p>
<p>American Cancer Society (ACS), 111–12, 172, 180, 259, 266, 296</p>
<p>American Cyanamid Corporation, 31</p>
<p>American Heart Association, 259</p>
<p>American Lung Association, 266</p>
<p>American Medical Association, 110, 251</p>
<p>American Society for the Control of Cancer (ASCC), 111, 112, 253,
254</p>
<p>see also American Cancer Society</p>
<p>American Society of Clinical Oncology (ASCO), 326–27, 427–29</p>
<p>American Surgical Association, 67–68, 78</p>
<p>Ames, Bruce, 277–78, 455–56</p>
<p>Ames test, 278, 303, 455–56</p>
<p>amethopterin, 143</p>
<p>see also VAMP regimen</p>
<p>aminopterin, 12, 33, 35, 36, 95, 96, 101, 121, 162, 220, 406, 433</p>
<p>aminotriazole, 457</p>
<p>anatomy:</p>
<p>cancer’s distortion of, 59</p>
<p>Halsted’s study of, 61</p>
<p>Vesalius’s study of, 51–53</p>
<p>Anatomy of Melancholy, The (Burton), 335</p>
<p>Andersson, Ingvar, 300</p>
<p>anemia, 27–29, 30, 31, 88, 203</p>
<p>folic acid and, 31</p>
<p>anesthesia, 56, 58, 62–63</p>
<p>angiogenesis, 387, 388, 389, 391, 407, 443, 458</p>
<p>aniline, 81–82, 84, 87, 340, 432</p>
<p>antagonists, 31, 36</p>
<p>antibiotics, 21–22, 122</p>
<p>development of, 131, 229</p>
<p>resistance to, 132</p>
<p>antibodies, 84, 410–11</p>
<p>for Her-2, 416–22</p>
<p>humanizing of, 418–19</p>
<p>antiemetics, 205–6</p>
<p>antiestrogen, 216</p>
<p>antifolates, 29, 31, 33, 34, 35, 87, 91, 92, 95, 96, 100, 103, 114,
121, 136, 162, 406</p>
<p>antimalaria drugs, 130</p>
<p>antinausea drugs, 226</p>
<p>anti-oncogenes, see tumor suppressor genes</p>
<p>antisepsis, 57–58</p>
<p>antitobacco campaigns, 401, 446</p>
<p>Antman, Karen, 426</p>
<p>Apollo space program, 178–79, 186</p>
<p>Archaemedes, 48</p>
<p>asbestos, 276–77, 278, 388, 390, 456</p>
<p>Asclepius, 40</p>
<p>asparaginase, 127</p>
<p>associations, as characteristic of American culture, 107–8</p>
<p>Atacama Desert, mummies of, 42–43, 45</p>
<p>Atlantic Monthly, 264</p>
<p>atomic bomb, 119</p>
<p>Atossa, Queen of Persia, 5, 41–42</p>
<p>thought experiment involving, 463–65, 467</p>
<p>ATP, 31</p>
<p>Au antigen, 279–80</p>
<p>Auden, W. H., 448</p>
<p>Auerbach, Oscar, 258–59, 284, 286, 289, 384–85, 386</p>
<p>Aufderheide, Arthur, 42–44, 45</p>
<p>Australian aborigines, 279</p>
<p>autopsy, meaning of word, 53</p>
<p>Avastin, 443</p>
<p>Avedon, Richard, 303</p>
<p>Avery, Oswald, 344–45</p>
<p>bacteria, 163, 346</p>
<p>as carcinogens, 281–84, 303</p>
<p>as cause of infection, 57</p>
<p>lateral transmission of genes in, 344</p>
<p>mutations of, 277–78, 455</p>
<p>as research subjects, 20, 204, 277–78, 349, 455</p>
<p>Bailar, John, 229, 230–34, 329–32</p>
<p>Baillie, Matthew, 53–54</p>
<p>Bainbridge, William, 32</p>
<p>Baltimore, David, 353, 354, 371, 431</p>
<p>Bang the Drum Slowly, 181</p>
<p>Bannister, Roger, 439</p>
<p>Banzhaf, John, 265–66, 401</p>
<p>Barbacid, Mariano, 374, 376</p>
<p>Bari, Italy, 89–90</p>
<p>Barnes Hospital, 72, 256–57</p>
<p>Bayer, 87</p>
<p>Bayne-Jones, Stanhope, 260</p>
<p>Bazell, Robert, 429</p>
<p>Bcr-abl oncogene, 431, 433–34, 435, 467–68</p>
<p>Gleevec-resistant, 442</p>
<p>Bcr gene, 431</p>
<p>Beadle, George, 345</p>
<p>Beatson, George, 214, 215, 216, 217, 456, 466</p>
<p>Becquerel, Henri, 73–74</p>
<p>Bellevue Hospital, 61–62</p>
<p>Belloc, Hilaire, 11</p>
<p>Bennett, John, 12–13, 14, 16, 44, 341, 365, 430, 431, 466</p>
<p>benzene compounds, 278</p>
<p>Beowulf, 363</p>
<p>Berne, Germaine, 467–70</p>
<p>Berry, Donald, 301, 320, 402</p>
<p>Bertipaglia, Leonard, 49</p>
<p>Beth Israel hospital, 313, 321</p>
<p>Bezwoda, Werner, 321, 323–24, 326–28</p>
<p>Biermer, Michael Anton, 17</p>
<p>biliary cancer, 381</p>
<p>Billroth, Theodor, 58–59, 62, 67</p>
<p>Bishop, J. Michael, 352, 359–63, 364, 365, 369, 370, 371, 375, 380,
418</p>
<p>black bile, 48–50, 53, 79, 214</p>
<p>black fever, 245</p>
<p>bladder cancer, 71</p>
<p>Blake, William, 237</p>
<p>blasts, 3, 17, 34, 35</p>
<p>Blatnik, John, 263</p>
<p>bleomycin, 205, 206</p>
<p>blood:</p>
<p>hematopoietic stem cells and, 458</p>
<p>in theory of humors, 48, 53</p>
<p>umbilical, 398–99</p>
<p>see also red blood cells; white blood cells</p>
<p>blood antigens, 279–80</p>
<p>blood-brain barrier, 147, 167</p>
<p>Bloodgood, Joseph, 65</p>
<p>blood tests, 2, 3, 7</p>
<p>blood transfusions, 196, 280</p>
<p>Blumberg, Baruch, 278–81</p>
<p>Bobst, Elmer, 172, 185</p>
<p>Bologna, Italy, 434–35</p>
<p>Bombay, India, 28–29, 30</p>
<p>Bonadonna, Gianni, 220–21, 222, 228</p>
<p>Bone, Homer, 25, 26</p>
<p>bone marrow:</p>
<p>biopsies of, 7, 17–18, 36, 147</p>
<p>as blood cell factory, 17–18, 29, 309, 407, 458</p>
<p>effect of nitrogen mustard on, 88, 90</p>
<p>leukemia in, 35, 136, 306–7</p>
<p>bone marrow transplants, 398–99, 421</p>
<p>allogeneic, 309, 434–35, 437</p>
<p>bone marrow transplants, autologous (ABMTs), 308, 309–10</p>
<p>Bezwoda’s claimed successes with, 323–24, 326–37</p>
<p>Bezwoda’s falsified data on, 327–28</p>
<p>dearth of clinical trials for, 325–26</p>
<p>escalating use of, 321–27</p>
<p>legal mandates for, 325</p>
<p>lethal complications associated with, 326, 328</p>
<p>secondary cancer as risk of, 325, 328</p>
<p>STAMP protocol for, 310, 311–15, 320, 325, 326, 328–29</p>
<p>bone tumors (osteosarcomas), 43</p>
<p>bortezomib (Velcade), 443</p>
<p>Boston Braves, 97–99, 102, 172</p>
<p>Boston Red Sox, 102, 172</p>
<p>Botstein, David, 418, 427</p>
<p>Boveri, Theodor, 341–42, 343, 348, 350, 365, 366, 390</p>
<p>Boyd, Norman, 299</p>
<p>Bradfield, Barbara, 419–22, 454</p>
<p>brain:</p>
<p>radiation therapy and, 127</p>
<p>as “sanctuary” for leukemia, 127, 146–47, 442</p>
<p>brain cancer:</p>
<p>genomes of, 450–52</p>
<p>radiation therapy for, 77</p>
<p>surgical removal of, 71–72</p>
<p>Brandt, Allan, 242</p>
<p>BRCA-1 gene, 381, 457, 464</p>
<p>BRCA-2 gene, 457, 464</p>
<p>breast cancer:</p>
<p>adjuvant chemotherapy for, 220–21, 222, 402, 464</p>
<p>as age-related, 302</p>
<p>of Atossa, 5, 41–42, 463–65</p>
<p>bone marrow transplants and, 312–13, 314, 320, 321–29</p>
<p>chemotherapy for, 122–23, 162, 232, 306, 308–9, 329, 427–28</p>
<p>cure rate of, 233, 326</p>
<p>ER-positive vs. ER-negative, 215, 221, 222–23, 456, 464</p>
<p>genomes of, 450, 451, 457, 464</p>
<p>Halsted and, 6, 23, 60, 64–69, 70–71, 73, 78, 173, 193–95, 196, 197,
198, 218, 225, 291, 463</p>
<p>Her-2 positive, 413–22, 423–29, 454, 464</p>
<p>heritability of, 346, 381</p>
<p>hormonal therapies for, 214–17, 218, 221–22, 456, 464, 466</p>
<p>inflammatory, 41–44</p>
<p>local surgery (lumpectomy) combined with radiation for, 195–96, 197,
201, 464</p>
<p>metastasis of, 67, 76, 161, 197, 217, 218, 221, 302–3, 314, 322, 325,
329, 419, 422, 424, 463, 465</p>
<p>mortality rates in, 296, 297, 300–301, 401–2, 465</p>
<p>radiation therapy for, 75–76, 77, 158, 161, 195–96, 201, 464</p>
<p>relapses of, 64, 66–69, 197, 208, 221, 329, 419</p>
<p>remissions in, 217, 222, 314, 454, 456</p>
<p>risk of, 44, 303, 457–58</p>
<p>screening and, 457, 464; see also mammography</p>
<p>stages of, 67, 218, 222, 428, 463, 464</p>
<p>surgeons as dominating field of, 219</p>
<p>surgery on, 58, 59, 62, 195–96, 197, 201, 402, 456, 464; see also
mastectomies</p>
<p>targeted therapies for, 413–22, 443, 454, 464, 465</p>
<p>as unmentionable topic, 26–27</p>
<p>Breast Cancer Action (BCA), 425–26</p>
<p>Breast Cancer Action Newsletter, 423</p>
<p>Breast Cancer Detection and Demonstration Project (BCDDP), 296–98,
302</p>
<p>Breast Cancer Symposium, 320</p>
<p>breast exams, 295n</p>
<p>breast MRIs, 457, 464</p>
<p>Brenner, Sydney, 345</p>
<p>Brian’s Song, 181</p>
<p>Brigham and Women’s Hospital, 30, 189</p>
<p>Bristol-Myers Squibb, 442</p>
<p>British American Tobacco, 274</p>
<p>British Medical Journal, 246</p>
<p>broadcast media:</p>
<p>cigarette advertising on, 265–67</p>
<p>fairness doctrine for, 265–66, 267</p>
<p>Broder, Samuel, 135</p>
<p>Brodeur, Paul, 267</p>
<p>bronchogenic carcinoma, 244</p>
<p>Brown, John, 60</p>
<p>Brown andandandand Williamson, 273</p>
<p>Brugge, Joan, 358</p>
<p>Brunschwig, Alexander, 70–71</p>
<p>Buchdunger, Elisabeth, 433, 435</p>
<p>Buffleben, Gracia, 423, 425</p>
<p>Burchenal, Joseph, 92, 130, 132, 167n, 184, 338</p>
<p>Burdette, Walter, 261</p>
<p>Burkitt, Denis, 174–75</p>
<p>Burkitt’s lymphoma, 174–75, 207</p>
<p>Burroughs Wellcome laboratory, 91, 92</p>
<p>Burstein, Harold, 447</p>
<p>Burton, Robert, 335</p>
<p>Bush, Vannevar, 118–21, 122, 183, 404</p>
<p>BusinessWeek, 111</p>
<p>BVP regimen, 205</p>
<p>Byron, George Gordon, Lord, 38</p>
<p>Cairns, John, 227–29, 231, 350</p>
<p>California, University of:</p>
<p>at Los Angeles (UCLA), 415, 417, 418, 420–21, 424</p>
<p>at San Francisco (UCSF), 359–60, 418, 424</p>
<p>Calvino, Italo, 412</p>
<p>Camel cigarettes, 268</p>
<p>Canadian National Breast Screening Study (CNBSS), 298–300, 302</p>
<p>cancer:</p>
<p>Achilles’ heels of, 405–7, 443</p>
<p>adaptability of, 38, 387</p>
<p>as age-related disease, 6, 44, 230, 300–303</p>
<p>in ancient world, 40–42, 43–44, 47–49</p>
<p>causes of, see carcinogenesis</p>
<p>cell growth in, see hyperplasia, pathological</p>
<p>centrifugal theory of, 194–95, 199</p>
<p>chemotherapy for, see chemotherapy</p>
<p>children with, 123, 331</p>
<p>as clonal disease, 39</p>
<p>commonalities of, 333</p>
<p>detection of, 44</p>
<p>as doppelgänger, 38–39</p>
<p>drug resistance in, 441–43</p>
<p>Galen’s theory of, 48–50, 53–54, 55, 79, 90, 214, 238, 281, 342, 434,
463</p>
<p>hallmarks of, 390–92, 407, 443, 449</p>
<p>heritability of, 253, 346–47, 381</p>
<p>heterogeneity of, 390, 465</p>
<p>as iconic “modern” illness, 38, 241</p>
<p>immortality of, 6, 312, 458–59</p>
<p>increasing rate of, 24</p>
<p>limitless replicative potential of, 391</p>
<p>local to systemic progression of, 405</p>
<p>as metaphor for social and political ills, 182–83</p>
<p>metastasis of, see metastasis, metastases</p>
<p>as migratory, 386, 387, 388, 391, 442, 467</p>
<p>morphological change in cells of, 288–89</p>
<p>mortality rates of, see mortality rates, of cancer</p>
<p>mutation in, see mutation, genetic</p>
<p>natural anatomy distorted by, 59</p>
<p>as “normal,” 449, 459</p>
<p>origin of term, 47</p>
<p>perceived as infectious, 175</p>
<p>perceived as single disease, 155, 173, 332–33</p>
<p>presymptomatic stages of, 290</p>
<p>in public discourse, 111–13, 181–83</p>
<p>radiation as cause of, 77–78, 173</p>
<p>radiation therapy for, see radiation therapy</p>
<p>Red Queen syndrome and, 443, 444, 446, 470</p>
<p>relative malignancy of, 292</p>
<p>as resistant to cell death signals, 391, 402, 407</p>
<p>as revealed by longevity, 44</p>
<p>six-degrees-of-separation rule for, 412</p>
<p>smoking and, see tobacco-cancer link</p>
<p>social challenge of, 447</p>
<p>social change as affecting incidence of, 44–45</p>
<p>specificity of, 80–81, 84–88, 90–92, 210, 222, 433</p>
<p>stages of, 55, 67, 160–61, 163, 164–65, 289, 290, 384–86, 463</p>
<p>surgery for, see surgery</p>
<p>survival rates of, 292–93</p>
<p>as systemic disease, 79, 80, 138, 172, 405</p>
<p>targeted therapies for, see targeted therapies</p>
<p>tumors, see tumors</p>
<p>see also specific cancers</p>
<p>Cancer: The Evolutionary Legacy, 46</p>
<p>“Cancer: The Great Darkness,” 23–24</p>
<p>Cancer and Leukemia Group B (CALGB), 320</p>
<p>Cancer Chemotherapy National Service Center (CCNSC), 122</p>
<p>Cancer Genome Atlas, 450–54</p>
<p>Cancer Genome Atlas consortium, 450–51</p>
<p>cancer patients:</p>
<p>access to experimental therapies demanded by, 319, 321–23, 423–26</p>
<p>doctors’ relationships with, 199, 202, 209, 306–8, 449</p>
<p>identity of, as obliterated by cancer, 4, 398</p>
<p>and Internet chat rooms, 438, 467</p>
<p>“seventh sense” of, 2</p>
<p>side effects and, 209, 305–6</p>
<p>stigmatization of, 126, 316</p>
<p>cancer prevention, 229–30, 233–34, 238–39, 242, 281, 455–58</p>
<p>Ames test and, 278, 303, 455–56</p>
<p>Auerbach’s research and, 258–59, 284, 286, 289</p>
<p>primary vs. secondary, 290</p>
<p>risk factors and, 44, 276, 303, 445–46, 455–57</p>
<p>screening in, see screening</p>
<p>smoking and, see tobacco-cancer link</p>
<p>social networks and, 445–46</p>
<p>understanding of carcinogenesis as critical to, 284–85, 303</p>
<p>cancer registry, 227–28</p>
<p>cancer research:</p>
<p>boldness vs. caution in, 130, 137–38, 139, 140, 144, 164, 166, 167,
208, 310</p>
<p>clinical trials in, see protocols</p>
<p>clinical vs. laboratory-based, 337, 339, 354–55, 375, 402, 404,
455–56</p>
<p>Congress and, 24–25, 113–14, 122, 150, 177, 184–89, 455</p>
<p>effect of AIDS crisis on, 319</p>
<p>as historically underfunded, 23–25</p>
<p>“one cause, one cure” approach in, 93, 155, 173, 223, 332–33, 342–43,
403</p>
<p>relevance of past in, 466</p>
<p>understanding of carcinogenesis downplayed in, 304</p>
<p>World War II and, 26</p>
<p>see also specific cancers, researchers, and therapies</p>
<p>Cancer Research, 254</p>
<p>“cancer stem cells,” 458–59</p>
<p>“Cancer Undefeated” (Bailar and Gornik), 330–32</p>
<p>Cancer Ward (Solzhenitsyn), 4, 181, 316, 461</p>
<p>Canellos, George, 159, 162, 163, 164, 207, 220, 312, 313</p>
<p>Cantor, David, 235</p>
<p>Cantor, Eddie, 94</p>
<p>carbolic acid, 57–58, 62</p>
<p>Carbone, Paul, 219–20</p>
<p>Carboplatin, 403–4</p>
<p>carcinogenesis, 285</p>
<p>Auerbach’s research on, 258–59, 284, 286, 289, 384–85, 386</p>
<p>chromosomes and, 341–42, 343, 348, 365–66, 402</p>
<p>as downplayed by researchers, 304</p>
<p>epidemiology and, 276</p>
<p>genetic mutation as mechanism of, 6, 39, 176, 278, 357, 362, 364–69,
370, 380–83, 384–88, 390–92, 403, 406, 449–50, 462, 464–65</p>
<p>internal vs. external agents in, 342, 349, 350</p>
<p>molecular model of, 388–90</p>
<p>premalignant stages of, 385</p>
<p>prevention as dependent on understanding of, 284–85, 303</p>
<p>risk factors and, 44, 276, 303, 349, 445–46, 455–57</p>
<p>somatic mutation hypothesis of, 173–74</p>
<p>two-hit hypothesis for, 367–69, 376, 377, 380</p>
<p>unitary cause of, 342, 347, 348, 390</p>
<p>Varmus/Bishop (proto-oncogene) theory of, 361–63, 364, 369, 370, 375,
380</p>
<p>carcinogens:</p>
<p>bacterial, 281–84, 303</p>
<p>chemical, 276–77, 388, 446</p>
<p>DNA as damaged by, 75, 77, 122, 351, 406, 462</p>
<p>environmental, 173–74, 176, 238, 349, 388, 446, 456–57</p>
<p>genes as, see oncogenes; tumor suppressor genes</p>
<p>genetic mutation caused by, 278, 362, 364</p>
<p>inflammations as, 281, 284, 303, 340, 388, 456n</p>
<p>mutagens as, 278, 303, 347, 348, 362, 364, 406, 456</p>
<p>radiation as, 77–78, 347, 349, 364, 389</p>
<p>tobacco as, see tobacco-cancer link</p>
<p>viral, 173, 174–76, 278–81, 303, 342–43, 349–50, 351–56, 357, 362</p>
<p>Carey, William, 180</p>
<p>Carroll, Lewis, 357, 360, 362, 441, 443</p>
<p>Carson, Rachel, 199–200, 456</p>
<p>Carter, Paul, 419, 420, 427</p>
<p>case-control studies, 245, 246–47, 276, 280, 294</p>
<p>Castle, William, 11</p>
<p>causality:</p>
<p>in disease, 253–56, 290</p>
<p>Hill’s postulates for, 255–56</p>
<p>Koch’s postulates for, 254, 382</p>
<p>see also carcinogenesis; carcinogens</p>
<p>Cautions against the Immoderate Use of Snuff (Hill), 239–40, 276</p>
<p>Cavenee, Webster, 376, 377</p>
<p>cell death (apoptosis), 391, 402, 407</p>
<p>cell growth:</p>
<p>hyperplastic, see hyperplasia</p>
<p>hypertrophic, 15</p>
<p>neoplastic, see neoplasia</p>
<p>cell phones, glioma and, 446–47</p>
<p>cells:</p>
<p>membranes of, 410–11</p>
<p>normalcy vs. abnormalcy of, 449, 459</p>
<p>cellular theory of disease, 14–16</p>
<p>Centers for Disease Control (CDC), 315</p>
<p>cervical cancer, 381n</p>
<p>Pap smears and, 288–90, 331, 385, 401</p>
<p>premalignant stage of, 385</p>
<p>CGP57148, see Gleevec</p>
<p>Chabner, Bruce, 304, 405, 439</p>
<p>Chappaquiddick scandal, 179</p>
<p>Charlotte’s Law, 325</p>
<p>“chemical castration,” 213, 215</p>
<p>chemicals, synthetic, 81–86, 91, 277</p>
<p>medicine and, 83–84</p>
<p>chemical stains, 84–85</p>
<p>Chemical Warfare Unit, 90, 92</p>
<p>chemotherapy, 7, 114, 304, 355, 448</p>
<p>adjuvant, 219, 220–21, 222, 223, 320, 400, 464</p>
<p>bone marrow transplants in, see bone marrow transplants</p>
<p>for breast cancer, 122–23, 162, 232, 306, 308–9, 427–28</p>
<p>“cancer stem cells” and, 458–59</p>
<p>cure rates for, 228, 231; see also specific cancers</p>
<p>as cytotoxic, 43–44, 143n, 162–63, 165, 168, 176, 207, 208, 220, 223,
305, 309, 312, 320, 405, 427–28, 452</p>
<p>dose limits of, 309</p>
<p>Ehrlich and, 84–88</p>
<p>fixed percentage of cells killed by, 141</p>
<p>high-dose multidrug regimens in, 132–34, 135, 140–43, 162, 163, 166,
167, 172, 173, 176–77, 204–5, 207–9, 216, 232, 305, 306, 308–9, 329,
389, 400, 443, 452; see also bone marrow transplants; specific
regimens</p>
<p>for Hodgkin’s lymphoma, 163–66, 208, 308, 315, 401</p>
<p>immune system compromised by, 165, 315</p>
<p>indiscriminate use of, 210</p>
<p>for leukemia, 19–20, 21, 27, 29–30, 31, 33–36, 92, 100, 101, 103–4,
122, 132–34, 135, 140–42, 167–70, 308, 339, 401, 443</p>
<p>for lung cancer, 308–9, 389, 403–4, 443</p>
<p>for lymphomas, 90–91, 96–97, 122, 132–34, 135, 162, 401, 443</p>
<p>nontoxic, 439</p>
<p>radiation in combination with, 123–24, 154, 168–70, 400</p>
<p>secondary cancers as outcome of, 165, 306, 312</p>
<p>side effects of, 18, 96, 123, 165, 205–6, 209, 226, 305</p>
<p>specific affinity in, 80–81, 84–88, 90–92, 433, 434, 439</p>
<p>sterility caused by, 165</p>
<p>surgeons’ hostility to, 219–21</p>
<p>targeted, see targeted therapies</p>
<p>for tumors, 122–23, 154, 207, 308–9</p>
<p>as universal cure, 93</p>
<p>white blood cells and, 127, 315</p>
<p>Chesterfield cigarettes, 268</p>
<p>Chiari, Hans, 62</p>
<p>Chicago Tribune, 187, 189, 235</p>
<p>chickens, sarcomas in, 173, 174</p>
<p>child labor, 239</p>
<p>children:</p>
<p>cancer in, 123, 331</p>
<p>leukemia in, 7, 12, 17, 19, 32–36, 92, 96, 101, 103–4, 123, 133, 139,
163, 166, 170, 179, 231, 232, 401</p>
<p>Children’s Cancer Research Fund, see Jimmy Fund</p>
<p>Children’s Hospital (Boston), 11–12, 19, 22, 27, 29, 30, 33, 34, 94,
95–96, 97, 99, 101, 387</p>
<p>Children’s Hospital (Buffalo), 133</p>
<p>chimeras, 366, 409–10, 430–31</p>
<p>Chimney Sweepers Act (1788, British), 239</p>
<p>chimney sweeps, 173, 237–39, 241</p>
<p>China, cigarette consumption in, 273–74</p>
<p>Chiribaya mummies, 42–43, 45</p>
<p>chloramphenicol, 22</p>
<p>cholesterol, 444</p>
<p>choriocarcinoma, 135–36, 139, 168, 228</p>
<p>choriogonadotropin (hcg), 136, 137, 138</p>
<p>Christakis, Nicholas, 445</p>
<p>Christie, Agatha, 444</p>
<p>Christie Hospital, 216–17</p>
<p>chromosomes, 340</p>
<p>in cancer cells, 341–42, 343, 348, 430–31</p>
<p>genes as carried on, 344</p>
<p>pairing of, 377</p>
<p>staining of, 340, 365</p>
<p>translocation of, 365–66, 402, 409–10, 430–31</p>
<p>chronic myeloid (myelogenous) leukemia (CML), 365–66, 430–31, 433,
444</p>
<p>bone marrow transplants and, 434–35, 437</p>
<p>drug resistance in, 441–43</p>
<p>Gleevec trial for, 436–38</p>
<p>remissions of, 437–39, 441, 443, 465</p>
<p>Ciba-Geigy, 431–32, 433–34, 436</p>
<p>cigarettes:</p>
<p>consumption of, see smoking</p>
<p>filter tips on, 263, 268</p>
<p>warning label on, 264–65, 267, 273, 401</p>
<p>see also nicotine; tobacco; tobacco industry</p>
<p>Cipollone, Anthony, 268, 270</p>
<p>Cipollone, Rose, 267–72, 273, 401</p>
<p>cirrhosis, chronic, 279</p>
<p>cisplatin (cis-platinum), 203–4, 205, 208, 406, 421</p>
<p>nausea from, 205–6</p>
<p>cis-retinoic acid, 408–9</p>
<p>c-kit gene, 467–68</p>
<p>Claire-King, Mary, 381</p>
<p>Clauson, Phyllis, 395–96, 397</p>
<p>Cleland, John, 204–5</p>
<p>Clements, Earle, 264</p>
<p>Cleveland Clinic, 196</p>
<p>clinical trials, see protocols</p>
<p>clones, 39</p>
<p>clotting factors, 415</p>
<p>CMF regimen, in adjuvant chemotherapy, 220–21</p>
<p>CML, see chronic myeloid (myelogenous) leukemia</p>
<p>c-myc (myc) gene, 382–83, 384, 391, 410, 412, 453–54, 458</p>
<p>cocaine, 62–63, 225</p>
<p>Cochran, William, 259, 261</p>
<p>Codman, Ernest, 30n</p>
<p>Cold Spring Harbor Laboratory, 403</p>
<p>Cold War, 182</p>
<p>Cole, Mary “Moya,” 216–17, 218–19, 221</p>
<p>Coley, William B., 30n</p>
<p>Coley’s toxin, 30n</p>
<p>Collett, Mark, 358</p>
<p>Collins, Francis, 450</p>
<p>colon cancer, 59, 116–17, 208, 331, 381, 401, 443, 450, 451</p>
<p>colonoscopy, 331, 401</p>
<p>Commission on the Conquest of Cancer, 184</p>
<p>“compassionate use” issue, experimental therapies and, 423–26</p>
<p>complexity, 20</p>
<p>compound 606 (Salvarsan), 86</p>
<p>Comprehensive Cancer Centers, 208</p>
<p>Conant, Marcus, 317</p>
<p>concentration camps, 397</p>
<p>“Concerning the Origin of Malignant Tumors” (Boveri), 342</p>
<p>Congress, U.S.:</p>
<p>antiregulatory posture of, 262</p>
<p>cancer research and, 24–25, 113–14, 122, 150, 177, 184–89, 455</p>
<p>tobacco industry and, 260, 264</p>
<p>Congress for Internal Medicine, 86</p>
<p>Conquest of Cancer Act (Kennedy/Javits bill), 185–86, 187</p>
<p>Cooper, Geoff, 374</p>
<p>Cooper case, 258</p>
<p>cotton, 81</p>
<p>cowpox, 342, 343</p>
<p>creatine, 31</p>
<p>Crick, Francis, 345</p>
<p>Crile, George, Sr., 196</p>
<p>Crile, George Barney, 68, 196–97, 198, 199</p>
<p>Crimean War, 240</p>
<p>cryptococcal meningitis, 316</p>
<p>CT scans, 389, 422</p>
<p>Cullman, Joseph, 262</p>
<p>Cummings, Karen, 396</p>
<p>Curd, John, 418, 424, 426</p>
<p>cure, patients’ expectations of, 22</p>
<p>Cure for Cancer: A National Goal (Garb), 177–78, 234</p>
<p>Cure of Childhood Leukemia, The (Laszlo), 21</p>
<p>Curie, Marie, 74–75, 76, 77</p>
<p>leukemia of, 78, 347</p>
<p>Curie, Pierre, 74–75, 76, 77</p>
<p>Cushing, Harvey, 65, 71–72</p>
<p>Cyclophosphamide, 127</p>
<p>Cyrus, King of Persia, 41</p>
<p>cytarabine, 127</p>
<p>cytotoxic drugs, 43–44, 143n, 162–63, 165, 168, 176, 207, 208, 220,
223, 305, 309, 312, 320, 405, 427–28, 452</p>
<p>Cytoxan, 162, 220, 427–28</p>
<p>Dakhleh, Egypt, 43</p>
<p>Dameshek, William, 146</p>
<p>Dana-Farber Cancer Institute, 153, 190, 310–14, 374, 433–34, 468</p>
<p>Institutional Review Board at, 312</p>
<p>D’Angio, Giulio, 123</p>
<p>Darius I, King of Persia, 41–42</p>
<p>dasatinib, 442–43</p>
<p>David, Ed, 186</p>
<p>Davis, Marvin, 171</p>
<p>DDT, 457</p>
<p>death, oncologists and, 4, 306–8, 337–38</p>
<p>decoy molecules, 31, 87</p>
<p>Degos, Laurent, 408–9, 410</p>
<p>de Gouvêa, Hilário, 347, 366, 367, 381</p>
<p>de Koning, H. J., 128</p>
<p>Delbruck, Max, 345</p>
<p>Democedes, 41–42</p>
<p>De Morbis Artificum Diatriba (Ramazzini), 238</p>
<p>deoxyribonucleic acid, see DNA</p>
<p>DES (diethylstilbestrol), 213, 277, 278</p>
<p>developing countries, tobacco-industry targeting of, 273–74</p>
<p>DeVita, Vincent, 151, 163–65, 171, 172, 220, 315</p>
<p>diabetes, 284, 414, 415</p>
<p>Diamond, Louis, 34</p>
<p>Dick, John, 458</p>
<p>Dickens, Charles, 239</p>
<p>Dickersin, Kay, 426</p>
<p>Dictionary of Practical Surgery, A, 55</p>
<p>Didion, Joan, 420</p>
<p>diethylstilbestrol (DES), 213, 277, 278</p>
<p>diphtheria, 84</p>
<p>disease(s):</p>
<p>Galen’s theory of, 48–50, 52–54, 55, 79, 90, 214, 238, 281</p>
<p>naming of, 14, 46–47</p>
<p>risk factors for, 444–45</p>
<p>Virchow’s cellular theory of, 14–16</p>
<p>Djozer, King of Egypt, 40</p>
<p>DNA (deoxyribonucleic acid), 360, 455</p>
<p>in cell division, 28–29, 75</p>
<p>as damaged by carcinogens, 75, 77, 122, 351, 406, 462</p>
<p>folic acid and, 28–29</p>
<p>inhibiting formation of, 91–92</p>
<p>mutations of, 6, 406, 462</p>
<p>nitrogen mustard as damaging to, 163, 406</p>
<p>reverse transcription from RNA to, 352–54, 371</p>
<p>transcription to RNA of, 352</p>
<p>transfer of, 372–74</p>
<p>see also genes, genomes</p>
<p>dogs, prostate cancer in, 212–13</p>
<p>Doisy, Edward, 213, 215</p>
<p>Doll, Richard, 243, 244, 273, 462, 465</p>
<p>lung cancer studies of, 245–49, 250–51, 253–54, 260, 262, 263, 276,
294, 350, 401, 455</p>
<p>Donne, John, 51</p>
<p>Dorchester, Mass., 32</p>
<p>Doyle, Arthur Conan, 9</p>
<p>Drebin, Jeffrey, 411n</p>
<p>Drew, Elizabeth, 265</p>
<p>Druker, Brian, 433–40</p>
<p>drug resistance, 132, 441–43</p>
<p>drugs, definition of, 413–14</p>
<p>Dryja, Thad, 376–80, 415</p>
<p>DuBridge, Lee, 183</p>
<p>Duesberg, Peter, 358</p>
<p>Duke University, 315, 319, 325, 326</p>
<p>Dulbecco, Renato, 350, 351, 371</p>
<p>dwarfism, 415</p>
<p>dye industry, 81–86</p>
<p>dyes, synthetic, 81–86, 278, 340</p>
<p>E. coli, 20</p>
<p>Edell, Marc, 269–71, 272</p>
<p>Edinburgh, Scotland, 298, 302</p>
<p>Edson, Margaret, 205, 209</p>
<p>Edwards, Ralph, 97–99, 396</p>
<p>Egan, Robert, 291</p>
<p>Egypt, ancient, 39–41, 463</p>
<p>Ehrlich, Paul, 80, 84–88, 237, 340, 432, 439</p>
<p>magic bullets of, 86–88, 222, 234, 304</p>
<p>Einhorn, Larry, 204–5, 208, 228</p>
<p>Einstein, Albert, 370</p>
<p>electrometer, 74</p>
<p>Eli Lilly, 31, 139</p>
<p>Elion, Gertrude, 91–92</p>
<p>Eliot, T. S., 191</p>
<p>“Ella” (VAMP protocol survivor), 148–50</p>
<p>Ellie: A Child’s Fight Against Leukemia (Tucker), 21</p>
<p>embryonic stem cells, 458</p>
<p>Enders, John, 22, 94</p>
<p>Endicott, Kenneth, 162, 171, 177, 260</p>
<p>environmentalists, 456</p>
<p>enzymes, viral, 352–53, 354</p>
<p>epidemiology, 238, 243, 245</p>
<p>case-control studies in, 245, 246–47, 276, 280</p>
<p>causality and, 253–56, 276, 290, 350</p>
<p>Framingham longitudinal data and, 444–45</p>
<p>meta-analysis and, 261</p>
<p>molecular, 457</p>
<p>preventive medicine and, 290, 457</p>
<p>recall bias in, 446</p>
<p>tobacco-cancer link and, 241–42, 247, 248–49, 250, 261</p>
<p>Epstein-Barr virus (EBV), 175</p>
<p>Erikson, Ray, 358, 361, 368, 375</p>
<p>Erk protein, 387, 454</p>
<p>Erwin, Bob, 429</p>
<p>esophageal cancer, 274, 305</p>
<p>estrogen, 211, 213, 456</p>
<p>breast cancer and, 215, 221, 222–23, 456, 464</p>
<p>receptor in, 215, 216, 217, 464</p>
<p>etoposide, 206</p>
<p>Evans, Audrey, 123</p>
<p>evolution, 39, 247–48</p>
<p>Ewing, James, 30n</p>
<p>extended field radiation, 159–61, 163</p>
<p>extirpations, 23</p>
<p>Faget, Max, 178</p>
<p>fairness doctrine, 265–66, 267</p>
<p>“Fall, The” (Milosz), 116</p>
<p>false positives, false negatives, 291–92</p>
<p>Farber, Emmanuel, 259, 261</p>
<p>Farber, Norma, 30</p>
<p>Farber, Sidney, 129, 162, 286, 395</p>
<p>as advocate for cancer research, 100, 171–72, 189</p>
<p>background of, 18–19</p>
<p>cancer research hospital project of, see Jimmy’s Clinic</p>
<p>cancer research of, 122–23, 126–27</p>
<p>chemotherapy regimens devised by, 103</p>
<p>chemotherapy seen as universal cure by, 93, 155, 403</p>
<p>colostomy of, 118</p>
<p>death of, 189–90, 193, 461</p>
<p>as fund-raiser, 102</p>
<p>isolation of, 27, 35, 101–2</p>
<p>at Jimmy’s Clinic, 125–26, 153, 189–90</p>
<p>leukemia research of, 19–20, 21, 27, 29–30, 31, 33–36, 92, 100, 101,
114, 121, 122–23, 130, 132, 136, 158, 309, 338, 433, 439</p>
<p>M. Lasker and, 114–15, 116, 122, 171, 177, 190</p>
<p>as pediatric pathologist, 11–12, 19</p>
<p>VAMP survivors and, 149–50</p>
<p>viral origin of cancer advocated by, 175</p>
<p>in War on Cancer, 114, 118, 122, 150, 155, 178, 184, 188, 190,
234</p>
<p>Federal Cigarette Labeling and Advertising Act (FCLAA; 1965), 264–65,
267, 273</p>
<p>Federal Communications Commission (FCC), 265–66</p>
<p>Federal Trade Commission (FTC), 263–64, 401</p>
<p>feminism, doctor-patient relationship and, 199</p>
<p>Fidler, Isaiah, 173</p>
<p>Fieser, Louis, 260–61</p>
<p>Figuoeroa, Rodolfo, 60</p>
<p>Fisher, Bernard, 198–99, 200, 219–20, 221–23, 228</p>
<p>Fitz, Katherine, 307–8, 400</p>
<p>5-fluorouracil, 154</p>
<p>Fleming, Alexander, 465–66</p>
<p>Flemming, Walther, 340, 341, 344, 364, 365</p>
<p>fluorouracil, 154, 220</p>
<p>foci, of cancer cells, 351, 372, 373–74, 376, 384</p>
<p>folic acid (folate), 28, 29, 31, 406</p>
<p>Folkman, Judah, 387</p>
<p>Food and Drug Administration (FDA), 262–63, 319, 322, 423, 429,
455</p>
<p>Foote, Emerson, 112, 113, 185</p>
<p>Ford, Edmund, 247–48</p>
<p>“Forsaken Garden, A” (Swinburne), 461</p>
<p>Fortas, Abe, 264</p>
<p>Fortune, 23–24, 25, 227</p>
<p>fossil record, 248</p>
<p>Fowler, James, 445</p>
<p>Fox, Nelene, 321–24</p>
<p>Fox Chase Cancer Center, 279</p>
<p>Framingham, Mass., longitudinal studies of, 444–45</p>
<p>Frankfurter Anilinfarben-Fabrik, 85</p>
<p>“Frank Statement to Cigarette Smokers, A,” 250, 252</p>
<p>Frei, Emil “Tom,” 129–30, 132, 133, 134, 137–38, 139, 140, 153,
162–64, 206, 228, 260, 375</p>
<p>at Dana-Farber, 310–14</p>
<p>STAMP and, 310, 311, 312, 314</p>
<p>VAMP and, 141–42, 143–47, 166, 310</p>
<p>Freireich, Emil, 128–30, 132, 134, 136, 137–38, 139, 140, 163–64,
206, 228, 260, 366</p>
<p>VAMP and, 141–42, 143–47, 166</p>
<p>Friend, Steve, 379–80</p>
<p>fruit flies, 344, 346, 347, 348, 349, 350</p>
<p>Furth, Jacob, 261</p>
<p>Galbraith, John, 23</p>
<p>Gale, Thomas, 48</p>
<p>Galen, Claudius, 46, 48–50, 52–54, 55, 79, 90, 158, 214, 238, 281,
342, 434, 463</p>
<p>gallbladder cancer, 465</p>
<p>Gallie, Brenda, 376, 377</p>
<p>Gallo, Robert, 318</p>
<p>gangrene, 57</p>
<p>Gans, Hiram, 461</p>
<p>Garb, Solomon, 177–78, 184, 234</p>
<p>gastritis, 276, 281–84</p>
<p>gastrointestinal stromal tumor (GIST), 467–70</p>
<p>Gay Men’s Health Crisis, 318</p>
<p>gay-related immune deficiency (GRID), see AIDS</p>
<p>Geller, Henry, 265–66</p>
<p>gemcitabine (Gemzar), 154</p>
<p>Genentech, 413, 414–19, 423–29</p>
<p>Herceptin trials of, 420–22, 424, 426–29, 430</p>
<p>Nelson’s “funeral procession” at, 425–26</p>
<p>genes, genomes, 6</p>
<p>as carcinogens, see oncogenes</p>
<p>as carried on chromosomes, 344</p>
<p>chimeras, 366, 409–10, 430–31</p>
<p>as composed of DNA, 345</p>
<p>functional view of, 364, 366, 368–69, 431, 455</p>
<p>inherited traits transmitted by, 343–44, 364, 366</p>
<p>mechanism of, 345–46, 364–69</p>
<p>mutations of, see mutation, genetic</p>
<p>RSV and, 351–52</p>
<p>sequencing of, 450–54, 464</p>
<p>structural view of, 364, 365–66, 431, 455</p>
<p>translocation of, 365–66, 402, 409–10, 430–31</p>
<p>tumor suppressor, see tumor suppressor genes</p>
<p>unidirectional flow of information from, 346, 352, 354</p>
<p>genetic anthropology, 278–79</p>
<p>Germany, dye industry in, 82–86</p>
<p>Ghosh, Amitav, 196</p>
<p>Gilbert, Rene, 159</p>
<p>Gilman, Alfred, 90</p>
<p>Gladwell, Malcolm, 302</p>
<p>Gleevec (imatinib):</p>
<p>CML and, 434–40, 441–43</p>
<p>as “four-minute mile” of cancer therapy, 439</p>
<p>GIST and, 467–68</p>
<p>resistance to, 441–43, 468</p>
<p>glioblastomas, 71</p>
<p>glioma, cell phones and, 446–47</p>
<p>Glück, Louise, 405</p>
<p>Goldman, John, 436</p>
<p>Goldstein, David, 124, 125–26</p>
<p>Goldstein, Sonja, 124–25</p>
<p>Goodfield, June, 1</p>
<p>Goodman, Louis, 90</p>
<p>Gorman, Michael, 393</p>
<p>Gornik, Heather, 330–32</p>
<p>Gould, Stephen Jay, 37</p>
<p>graft-versus-host disease (GVHD), 309, 437</p>
<p>Graham, Evarts, 72, 242, 260</p>
<p>laboratory experiments of, 254–55, 456</p>
<p>lung cancer and death of, 250, 256–57, 258</p>
<p>tobacco-cancer study of, 244–45, 246–47, 252, 253–54, 256, 260, 263,
401</p>
<p>Great Britain:</p>
<p>child labor in, 239</p>
<p>doctor registry in, 249, 294</p>
<p>dye industry in, 82</p>
<p>Million Women Study in, 456</p>
<p>textile industry in, 81–82</p>
<p>tobacco use in, 240</p>
<p>Great Depression, 109</p>
<p>Greaves, Mel, 46</p>
<p>Greco-Persian wars, 42</p>
<p>Greece, ancient, medical knowledge in, 47–48</p>
<p>Greene, Mark, 411n</p>
<p>growth hormone, 414, 415</p>
<p>Grubbe, Emil, 75–76, 77, 78, 195</p>
<p>Gustafson, Einar “Jimmy,” 96–99, 172, 395–97</p>
<p>Guy’s Hospital, 156</p>
<p>gynecological diseases, 287</p>
<p>Haagensen, Cushman, 193–94, 198</p>
<p>Haldane, J. B. S., 6</p>
<p>Halley’s comet, 370</p>
<p>“Hallmarks of Cancer, The” (Weinberg and Hanahan), 390–92, 443</p>
<p>Halsted, Caroline Hampton, 63</p>
<p>Halsted, William Stewart, 60–69, 158, 201, 219, 319</p>
<p>centrifugal theory of, 194–95, 199</p>
<p>drug addictions of, 62–64, 225</p>
<p>mistaken kindness scorned by, 65</p>
<p>radical surgery pioneered by, 6, 23, 60, 64–69, 70–71, 73, 78, 173,
193–95, 196, 197, 198, 218, 225, 291, 463</p>
<p>Hamill, Peter, 259</p>
<p>Hamlet (Shakespeare), 1</p>
<p>Hanafusa, Hidesaburo, 361, 368</p>
<p>Hanahan, Douglas, 390–92</p>
<p>Harlow, Ed, 403</p>
<p>Harmon, Steve, 305–6, 399</p>
<p>Harvard Medical School, 18–19, 27, 30</p>
<p>Harvey, Gideon, 83</p>
<p>Hayes, Daniel, 426</p>
<p>hcg (choriogonadotropin), 136, 137, 138</p>
<p>Health Net, 322–23, 324</p>
<p>Fox lawsuit against, 322, 324</p>
<p>heart disease, 45, 110, 259, 284</p>
<p>cholesterol and, 444</p>
<p>Heath, Jeff, 98</p>
<p>Heckler, Margaret, 318</p>
<p>Hegel, Georg, 202</p>
<p>Heister, Lorenz, 49</p>
<p>Helicobacter pylori, 282–84, 303, 456</p>
<p>Heller, John, 114</p>
<p>hematology, 27</p>
<p>hematopoietic stem cells, 458</p>
<p>hemophilia, 415</p>
<p>hepatitis:</p>
<p>acute, 280</p>
<p>chronic, 279, 340</p>
<p>hepatitis B virus (HBV), 280, 303</p>
<p>vaccine for, 281, 290</p>
<p>hepatocellular cancer, 280</p>
<p>Her-2 gene, 413, 414–21, 423, 425–29, 454, 464</p>
<p>Herceptin (Trastuzumab), 416–22, 455, 464</p>
<p>patient demands for access to, 423–26</p>
<p>648 trial of, 427–28</p>
<p>trials of, 420–22, 423, 424, 426–29, 430</p>
<p>heritability, of traits, 343–44, 364, 366</p>
<p>Hermann, I., 335</p>
<p>Herodotus, 41, 42</p>
<p>herpes, 342</p>
<p>Hertz, Roy, 135, 136–37</p>
<p>Hickam, John, 261</p>
<p>Hiepler, Mark, 322, 324</p>
<p>high blood pressure, 444</p>
<p>Hill, Austin Bradford, 243–44</p>
<p>causality postulates of, 255–56</p>
<p>lung cancer studies of, 245–46, 247, 248–49, 250, 253–54, 260, 262,
263, 276, 294, 350, 401, 455</p>
<p>randomization protocols developed by, 131–32, 243</p>
<p>Hill, John, 239–40, 276</p>
<p>Hill, Lister, 107, 117, 179, 184</p>
<p>HIP (Health Insurance Plan), 294–96, 297</p>
<p>Hippocrates, 47–48, 49, 155, 308, 463</p>
<p>“straight into” expression of, 52</p>
<p>Hippocratic oath, 70</p>
<p>Hiroshima, bombing of, 119</p>
<p>Histories (Herodotus), 41</p>
<p>Hitchings, George, 91, 92</p>
<p>HIV, 14n, 165, 318, 356, 424</p>
<p>HMOs (health maintenance organizations), 294</p>
<p>experimental therapy coverage denied by, 322, 324–25</p>
<p>Hodgkin, Thomas, 155–58</p>
<p>Hodgkin’s lymphoma, 152–53, 181, 222, 228, 399</p>
<p>B symptoms of, 152, 164</p>
<p>chemotherapy for, 163–66, 208, 308, 315</p>
<p>discovery of, 155–58</p>
<p>leukemia relapse as outcome of chemotherapy for, 165</p>
<p>as localized disease, 158, 161, 163</p>
<p>metastatic, 163</p>
<p>radiation therapy for, 159–61, 163</p>
<p>remission rate of, 160–61, 171, 179, 228, 231, 331, 400, 401, 465</p>
<p>stages of, 160–61, 163, 164–65</p>
<p>Hoechst Chemical Works, 86, 87</p>
<p>Hofmann, August, 83</p>
<p>Holland, James, 130, 167n, 184, 430</p>
<p>Holleb, Arthur, 296</p>
<p>homosexuals, AIDS and, 315–19</p>
<p>hormonal therapies:</p>
<p>adjuvant, 221–22, 223, 456</p>
<p>for breast cancer, 214–17, 218, 221–22, 456, 464, 466</p>
<p>for prostate cancer, 213–14, 222</p>
<p>hormones:</p>
<p>regulatory functions of, 211–12</p>
<p>synthetic, 277</p>
<p>see also specific hormones</p>
<p>hospices, 225–26</p>
<p>Hospital Dieu, 51</p>
<p>hospitals, proliferation of, 22</p>
<p>House of Representatives, U.S., 186–88</p>
<p>see also Congress, U.S.</p>
<p>House That “Jimmy” Built, The, 93</p>
<p>HTLV-1, 415</p>
<p>Huebner, Robert, 358n</p>
<p>Huggins, Charles, 210–13, 215, 216, 304</p>
<p>Human EGF Receptor (HER), 413</p>
<p>human genome, 451</p>
<p>cancer as inseparable from, 462</p>
<p>Human Genome Project, 450</p>
<p>human papillomavirus (HPV), 349n, 381n</p>
<p>humors, theory of, 48–50, 52, 79, 214, 463</p>
<p>Hungerford, David, 365</p>
<p>Hunter, David, 457</p>
<p>Hunter, John, 55–56, 58, 463</p>
<p>Hunting of the Snark (Carroll), 357, 360, 362</p>
<p>hydraulics, 48</p>
<p>hyperplasia, 15, 28–29, 140, 204</p>
<p>hyperplasia, pathological, 6, 15–16, 38–39, 47–48, 136, 140–41, 340,
348, 351, 355, 357–59, 369, 372, 376, 387, 391, 405–6, 458–59</p>
<p>as halted by nitrogen mustard, 163, 406</p>
<p>as impeded by X-rays, 75</p>
<p>as induced by oncogenes, 357–59, 372, 431</p>
<p>as interrupted by antifolates, 406</p>
<p>as vulnerability, 405–6</p>
<p>see also neoplasia</p>
<p>hypertrophy, 15</p>
<p>IDAV (immuno-deficiency associated viruses), see HIV</p>
<p>Illness as Metaphor (Sontag), 37–38, 316, 449</p>
<p>imatinib, see Gleevec</p>
<p>Imhotep, 40–41, 42, 55, 463</p>
<p>immune system:</p>
<p>AIDS and, 315–19</p>
<p>as compromised by chemotherapy, 165, 315</p>
<p>Imperial Chemical Industries (ICI), 216</p>
<p>India, cigarette consumption in, 273–74</p>
<p>infection:</p>
<p>as risk of surgery, 56–57</p>
<p>viral protein as sign of, 280</p>
<p>white blood cells in response to, 13, 16</p>
<p>infectious diseases:</p>
<p>causality and, 254</p>
<p>vectors for, 245</p>
<p>inflammation, as carcinogenic, 281, 284, 303, 340, 388, 456n</p>
<p>influenza, 46–47, 351</p>
<p>1918 pandemic of, 110</p>
<p>“In Memoriam, July 19, 1914” (Akhmatova), 461</p>
<p>Institute for Cancer Research, 279</p>
<p>Institut Pasteur, 318</p>
<p>insulin, 414, 415</p>
<p>insurance providers, experimental therapy coverage denied by,
321–25</p>
<p>Internet, patient chat rooms on, 438, 467</p>
<p>Invisible Cities (Calvino), 412</p>
<p>involved field radiation, 160</p>
<p>iron deficiency, 27–28</p>
<p>iron lungs, 94, 466</p>
<p>Istituto Tumori, 220</p>
<p>Jacob, François, 345</p>
<p>Javits, Jacob, 185</p>
<p>Jencks, Maggie Keswick, 328–29, 450</p>
<p>Jenner, Edward, 343</p>
<p>Jensen, Earl, 374</p>
<p>Jensen, Elwood, 215, 216, 217</p>
<p>Jimmy Fund, 96–99, 102, 108, 171–72, 190, 395</p>
<p>Jimmy’s Clinic, 96, 99–100, 102–4, 124–25, 172, 397</p>
<p>deaths at, 125–26</p>
<p>Farber at, 125–26, 153, 189–90</p>
<p>John Harvey, 89</p>
<p>John of Arderne, 49</p>
<p>Johns Hopkins Hospital, 63, 65, 450</p>
<p>Jordan, V. Craig, 217</p>
<p>Journal of the American Medical Association, 246</p>
<p>Kafka, Franz, 105</p>
<p>Kantarjian, Hagop, 438, 440</p>
<p>Kaplan, Henry, 158–61, 163, 166, 184, 222</p>
<p>Kaposi’s sarcoma, 315–17, 318</p>
<p>karkinos, 47–48, 463</p>
<p>Keats, John, 38</p>
<p>Keefer, Chester, 129</p>
<p>Kennedy, Edward, 179, 185</p>
<p>Kennedy, John F., 259–60</p>
<p>Kennedy/Javits bill (Conquest of Cancer Act), 185–86, 187</p>
<p>Kettlewell, Henry B. D., 248n</p>
<p>Keynes, Geoffrey, 193, 195–98, 199</p>
<p>kidney cancer, 71, 123–24</p>
<p>Kiltie, Harriet, 31, 33</p>
<p>kinase inhibitors, 432–34, 435, 442–43</p>
<p>kinases, 358–59, 361, 368, 431–32, 467–68</p>
<p>as “druggable,” 432</p>
<p>Klausner, Richard, 332, 465–66</p>
<p>Knudson, Alfred, 366–69, 376, 377, 380</p>
<p>Koch, Robert, 84, 254, 255, 382</p>
<p>Kohler, George, 417</p>
<p>Korean War, 135–36</p>
<p>Kornberg, Arthur, 349</p>
<p>Kornegay, Horace, 270</p>
<p>Korsmeyer, Stan, 387</p>
<p>Koster, Bill, 95–96, 97, 99, 102</p>
<p>Kramer, Larry, 318–19</p>
<p>Krumbhaar, Edward and Helen, 88, 90</p>
<p>Kushner, Rose, 114, 193, 200, 209, 405</p>
<p>L-1210 leukemia, 140–41</p>
<p>LaCombe, Michael, 128</p>
<p>Lancet, 301, 315, 316</p>
<p>Landers, Ann (Eppie Lederer), 185–86</p>
<p>LandandandandM cigarettes, 268</p>
<p>Landsteiner, Karl, 342</p>
<p>Lasker, Albert, 110–11</p>
<p>on ACS board, 112</p>
<p>as advertising genius, 109</p>
<p>colon cancer of, 116–17</p>
<p>Lasker, Mary Woodard, 375n, 393</p>
<p>ACS and, 112–13</p>
<p>background of, 108–9</p>
<p>campaign to raise public awareness of cancer, 112–13</p>
<p>death of, 403</p>
<p>as evangelist for medical research, 110–11</p>
<p>Farber and, 114–15, 116, 122, 171, 172, 177, 190</p>
<p>fund-raising by, 117</p>
<p>and husband’s cancer, 117</p>
<p>as socialite, 108, 111, 117</p>
<p>in War on Cancer, 113–14, 117–18, 122, 155, 177–78, 179, 183–86,
188–89, 191, 234, 296, 402, 403</p>
<p>Laskerites, 105, 113, 114, 115, 117, 118, 121, 155, 177, 178, 179,
183, 185, 188, 189, 234, 253, 318, 375</p>
<p>Lasker Prize, 188</p>
<p>Laszlo, John, 21</p>
<p>Lauder, Leonard, 102</p>
<p>Lawrence, D. H., 364</p>
<p>Leakey, Louis, 43</p>
<p>Leder, Philip, 382–83, 384</p>
<p>Lederle Labs, 31, 33</p>
<p>Lee, Philip, 186</p>
<p>Lee, Rose, 75–76</p>
<p>LeMaistre, Charles, 260</p>
<p>Leopold Cassella Company, 85</p>
<p>Lerner, Max, 398</p>
<p>Let Me Down Easy (Smith), 305</p>
<p>leukemia, 3, 260, 337, 375, 439, 451</p>
<p>acute myeloid (AML), 16–17</p>
<p>acute promyelocytic (APL), 407–10</p>
<p>in adults, 17, 306</p>
<p>antifolates and, 29, 31, 33, 35, 87, 91, 92, 95, 96, 100, 101, 103,
114, 121, 136, 162</p>
<p>bone marrow transplants for, 309</p>
<p>brain as “sanctuary” for, 127, 146–47, 442</p>
<p>“cancer stem cells” and, 458–59</p>
<p>chemotherapy for, 19–20, 21, 27, 29–30, 31, 33–36, 92, 100, 101,
103–4, 122, 132–34, 135, 140–42, 167–70, 308, 339, 401, 443; see also
specific regimens</p>
<p>in children, 7, 12, 17, 19, 32–36, 92, 96, 101, 103–4, 123, 133, 139,
163, 166, 170, 179, 231, 232, 401</p>
<p>chronic myeloid (myelogenous), see chronic myeloid (myelogenous)
leukemia</p>
<p>chronic vs. acute, 16</p>
<p>discovery of, 12–14</p>
<p>Farber’s research on, 19–20, 21, 27, 29–30, 31, 33–36, 95, 100, 101,
114, 121, 122–23, 130, 132, 136, 158, 309, 338, 433, 439</p>
<p>folic acid and, 29</p>
<p>L-1210, 140–41</p>
<p>Marie Curie’s death from, 78, 347</p>
<p>as measurable, 19</p>
<p>multiplicity of symptoms in, 13</p>
<p>naming of, 14</p>
<p>as outcome of chemotherapy for other cancers, 165, 306, 312</p>
<p>radiation therapy for, 168–70</p>
<p>relapses of, 35, 91, 132, 133, 147, 165, 166, 170, 442</p>
<p>remissions of, 34, 35, 101, 127, 133, 145–46, 179, 190</p>
<p>research consortium for, 130–31, 133, 144</p>
<p>vincristine and, 139–40</p>
<p>see also acute lymphoblastic leukemia</p>
<p>Levi, Primo, 394</p>
<p>Levinson, Art, 358n, 418, 427</p>
<p>Levittown, 22–23</p>
<p>Li, Min Chiu, 135–36, 139, 168, 219</p>
<p>Life, 24, 175</p>
<p>life expectancy, in U.S., 22, 45</p>
<p>Li-Fraumeni syndrome, 381</p>
<p>Liggett, 269–71</p>
<p>Lindskog, Gustaf, 90</p>
<p>linear accelerators, 158–59</p>
<p>Lister, Joseph, 57–58, 62</p>
<p>Little, Clarence Cook, 111, 112, 113, 253–54, 255, 263</p>
<p>liver cancer, 280, 290, 340</p>
<p>Lives of a Cell, The (Thomas), 430</p>
<p>Lockhart-Mummery, John, 286</p>
<p>London, Jack, 218</p>
<p>London School of Tropical Medicine, 245</p>
<p>Longoria, Ethel, 136</p>
<p>Lord and Thomas, 109</p>
<p>Lorde, Audre, 227</p>
<p>Lorillard Tobacco Company, 269–71, 273</p>
<p>Los Angeles Times, 73</p>
<p>Love Story, 181</p>
<p>lumpectomies, 194–95, 464</p>
<p>lung cancer, 45, 158, 388–90, 450, 451</p>
<p>chemotherapy for, 162, 308–9, 389, 403–4, 443</p>
<p>increased rate of, 231</p>
<p>mesothelioma, 276–77</p>
<p>metastasis of, 208, 256, 267, 269, 307, 389–90, 403</p>
<p>morbidity rates of, 243, 331</p>
<p>mortality rates of, 331, 401</p>
<p>premalignant stage of, 385</p>
<p>radiation therapy for, 158, 403</p>
<p>smoking and, see tobacco-cancer link</p>
<p>surgical removal of, 59, 72, 256</p>
<p>in women, 331</p>
<p>lung disease, 259</p>
<p>Lydon, Nick, 432–33, 434, 435</p>
<p>lymph nodes, 157</p>
<p>surgical removal of, 58, 65, 194</p>
<p>lymphoid cells, 17</p>
<p>lymphomas, 151–52, 228, 316</p>
<p>chemotherapy for, 90–91, 96–97, 122, 132–34, 135, 162, 401, 443</p>
<p>cure rate of, 233</p>
<p>Hodgkin’s, see Hodgkin’s lymphoma</p>
<p>radiation therapy for, 77, 158</p>
<p>relapses of, 91</p>
<p>Lynch, Henry, 381</p>
<p>Lynch, Thomas, 307–8, 403–4</p>
<p>Lynch syndrome, 381</p>
<p>McGregor, Marilyn, 429</p>
<p>Madagascar periwinkle, 139</p>
<p>magic bullets, 86–88, 222, 304</p>
<p>Magic Mountain, The (Mann), 38</p>
<p>Magnuson, Warren, 25</p>
<p>Magrath, Ian, 207</p>
<p>malaria, 245</p>
<p>Malmö, Sweden, 298, 300–301</p>
<p>Malmö Mammography Study, 300–301</p>
<p>malnourishment, anemia and, 28–29</p>
<p>mammography, 44, 228, 290–91</p>
<p>benefits of, as age-dependent, 300–302</p>
<p>Canadian trial (CNBSS) of, 298–300, 302</p>
<p>Edinburgh trial of, 298</p>
<p>HIP trial of, 294–96, 297</p>
<p>metastasis and, 302–3</p>
<p>mortality rates and, 296, 297, 300–301, 331–32, 402</p>
<p>NCI project (BCDDP) for, 296–98, 302</p>
<p>Swedish trials of, 298, 300–301</p>
<p>Manhattan Project, 119, 120, 186</p>
<p>Mann, Thomas, 38</p>
<p>March of Dimes, 94</p>
<p>marijuana, as antiemetic, 205</p>
<p>Marine Hospital, U.S., 26</p>
<p>Marlboro Man, 251</p>
<p>Marmite, 28</p>
<p>Marshall, Barry, 276, 281, 282–84, 456</p>
<p>Martin, Steve, 358</p>
<p>Masi, Phil, 97–98</p>
<p>Massachusetts, 325</p>
<p>Massachusetts General Hospital, 3, 56, 223, 320, 390, 398, 403, 437,
451</p>
<p>mastectomies, 49, 419</p>
<p>of Atossa, 5, 41–42, 463</p>
<p>disfigurement from, 65–66, 294</p>
<p>prophylactic, 457–58, 464</p>
<p>radical, 23, 64–72, 73, 109–10, 173, 193–95, 196, 197, 198–201, 202,
218, 219, 225, 294, 463</p>
<p>simple (local), 67, 197, 201, 464</p>
<p>success rate of, 66–69</p>
<p>Master Settlement Agreement (MSA), 273</p>
<p>Matter, Alex, 432–33</p>
<p>mauve, 81–82</p>
<p>Mayer, Robert, 130–31, 311, 326, 328</p>
<p>Mayfield, Jerry, 441, 442–43</p>
<p>MD Anderson Cancer Center, 147, 366, 438</p>
<p>measurement:</p>
<p>of leukemia, 19</p>
<p>of negative claims, 167–68</p>
<p>of radiation, 74</p>
<p>in War on Cancer, 227, 231, 232–33</p>
<p>Medical and Chirurgical Society, 157</p>
<p>Medical Journal of Australia, 283</p>
<p>Medical Research Council (British), 131, 243–44</p>
<p>Medical World News, 349</p>
<p>medicine:</p>
<p>synthetic chemistry and, 83–84</p>
<p>as technological art, 462</p>
<p>Mek protein, 387, 454</p>
<p>melanoma, 451</p>
<p>Memorial Sloan-Kettering, 92, 135, 138, 167n, 184, 234, 424</p>
<p>Mendel, Gregor, 343–44, 346, 364, 366, 369</p>
<p>meningiomas, 71</p>
<p>menopausal symptoms, 456</p>
<p>Mercer, Robert, 34</p>
<p>Merck, 21</p>
<p>Meselson, Matthew, 345</p>
<p>meta-analysis, 261</p>
<p>metastasis, metastases, 16, 38, 39, 55, 58, 123, 135, 136, 154, 161,
196–97, 204, 223, 391, 442, 465, 467</p>
<p>of breast cancer, 67, 76, 161, 217, 218, 302–3, 314, 322, 325, 329,
419, 422, 424, 463, 465</p>
<p>of Hodgkin’s lymphoma, 163</p>
<p>as inevitable, 79</p>
<p>of lung cancer, 208, 256, 267, 268, 307, 389–90, 403</p>
<p>methotrexate, 127, 132–33, 137, 138, 140, 162, 164, 219, 220, 338</p>
<p>Mexico, cigarette regulation in, 274</p>
<p>Meyer, Willy, 65, 78–79, 80, 219</p>
<p>mice, transgenic, 382–83, 384</p>
<p>microtubules, 140</p>
<p>Middle Ages, medical knowledge in, 49–50, 51–53</p>
<p>Million Women Study, 456</p>
<p>Milosz, Czeslaw, 116</p>
<p>Milstein, Cesar, 417, 419</p>
<p>Ministry of Health, British, 243</p>
<p>Ministry of Health, Mexican, 274</p>
<p>Minot, George, 27–28, 29</p>
<p>Mississippi, antitobacco lawsuit of, 272–73</p>
<p>mitosis, 451</p>
<p>mitosis, pathological, 348, 351, 355, 359, 387, 391</p>
<p>see also hyperplasia, pathological</p>
<p>Mizutani, Satoshi, 353</p>
<p>molecular biology, “central dogma” of, 346, 352, 354, 357</p>
<p>molecular pumps, 442</p>
<p>molecules:</p>
<p>decoy, 31, 87</p>
<p>structural view of, 432</p>
<p>as switches, 28</p>
<p>see also receptors</p>
<p>Moloney, William, 143</p>
<p>Monod, Jacques, 20, 345, 346</p>
<p>mononucleosis, 175</p>
<p>Montagnier, Luc, 318</p>
<p>Moore, Charles, 64</p>
<p>Moore, Michael, 272–73</p>
<p>MOPP, 164–66, 208</p>
<p>Morbid Anatomy of Some of the Most Important Parts of the Human Body,
The (Baillie), 53</p>
<p>Morgan, Thomas Hunt, 344, 346, 347–48, 364</p>
<p>Morison, Robert, 116</p>
<p>morphine, 63, 149, 225</p>
<p>mortality rates, of cancer, xi, 25, 105, 228–30, 293, 401</p>
<p>age-adjusted, 230–31, 232–33, 330</p>
<p>of breast cancer, 296, 297, 300–301, 401–2</p>
<p>dynamic equilibrium in, 330–31</p>
<p>mortality rates, of tuberculosis, 229</p>
<p>Morton, William, 56</p>
<p>motility, of cancer cells, 386, 387, 388</p>
<p>see also metastasis, metastases</p>
<p>MRIs, 457, 464</p>
<p>Mukherjee, Leela, 398</p>
<p>Mukherjee, Siddhartha:</p>
<p>Berne and, 467–70</p>
<p>and daughter’s birth, 398–99</p>
<p>as oncology fellow, 2–5, 168, 190, 305–6, 307–8, 337, 390, 398–99,
437–38, 467</p>
<p>Orman and, 152–53, 399–400</p>
<p>palliative care suggested by, 223–24</p>
<p>Reed and, 2–3, 7, 17–18, 127, 168–69, 190, 337, 338–39, 400,
448–49</p>
<p>Sorenson and, 153–55</p>
<p>tobacco-cancer link in patients of, 274–75</p>
<p>Muller, Hermann Joseph, 347–48</p>
<p>multidose regimens, see chemotherapy, high-dose multidrug regimens
in</p>
<p>multiple myeloma, 309, 443–44</p>
<p>mummies, cancer in, 43, 45</p>
<p>Murayama, Hashime, 288</p>
<p>Murphy, Mary Lois, 92</p>
<p>mustard gas, see nitrogen mustard</p>
<p>mutagens, mutagenesis, 278, 303, 347, 348, 362, 364, 406, 456</p>
<p>mutation, genetic, 377</p>
<p>in bacteria, 277–78</p>
<p>Cancer Genome Atlas and, 450–54</p>
<p>causes of, see mutagens, mutagenesis</p>
<p>driver (active), 453</p>
<p>frequency of, 451–52</p>
<p>in fruit flies, 347</p>
<p>functional vs. structural view of, 455</p>
<p>as governing all aspects of cancer, 387–88, 462</p>
<p>as mechanism of carcinogenesis, 6, 39, 176, 278, 357, 362, 370,
380–83, 384–88, 390–92, 403, 406, 449–50, 462, 464–65</p>
<p>passenger (passive), 452–53</p>
<p>see also oncogenes</p>
<p>myc (c-myc) gene, 382–83, 384, 391, 410, 412, 453–54, 458</p>
<p>mycobacteria, 84, 131</p>
<p>myelodysplasia, 306, 309, 312</p>
<p>myeloid cells, 16–17</p>
<p>Myriad Genetics, 381</p>
<p>Nathan, David, 140</p>
<p>National Alliance of Breast Cancer Organizations (NABCO), 327</p>
<p>National Breast Cancer Coalition (NBCC), 426, 429</p>
<p>National Cancer Act (1971), 188, 189</p>
<p>National Cancer Institute (NCI), 15, 114, 130, 158, 159, 166, 177,
188, 228, 231, 318, 325, 330, 339, 374, 393, 443</p>
<p>chemotherapy protocols of, 132–42, 143–50, 164–66, 206–8, 219–20,
232, 310, 317</p>
<p>Clinical Center of, 128–29, 139, 145, 162, 165, 260</p>
<p>creation of, 25–26</p>
<p>Institutional Board of, 137</p>
<p>mammography project (BCDDP) of, 296–98, 302</p>
<p>Pap smear trial of, 289–90</p>
<p>preventative strategies neglected by, 233–34</p>
<p>Special Virus Cancer Program of, 175–76, 280–81, 356, 357</p>
<p>National Cancer Institute Act (1937), 25</p>
<p>National Health Service, British, 294</p>
<p>National Institutes of Health (NIH), 25n, 121, 187, 188, 202–3, 260,
319</p>
<p>National Library of Medicine, 261</p>
<p>National Program for the Conquest of Cancer, 184</p>
<p>National Science Foundation (NSF), 121</p>
<p>National Surgical Adjuvant Breast and Bowel Project (NSABP),
200–201</p>
<p>National Tuberculosis Association, 259</p>
<p>natural selection, 248</p>
<p>Nature, 354, 379</p>
<p>Nature Medicine, 435</p>
<p>nausea, from chemotherapy, 165, 205–6, 209, 226, 305</p>
<p>Nazis, 290</p>
<p>Neely, Matthew, 25, 173</p>
<p>negative statistical claims, 197–98</p>
<p>Nelson, Marti, 424–25, 429</p>
<p>“funeral procession” for, 425–26</p>
<p>neoplasia, 16, 42, 385</p>
<p>neu, 410–11, 412, 413, 420</p>
<p>neuroblastomas, 410, 413</p>
<p>New England Journal of Medicine, 35–36, 161, 229, 330, 385</p>
<p>Newton, Isaac, 370</p>
<p>New York, HIP in, 294–96, 297</p>
<p>New York, N.Y., AIDS in, 316, 318</p>
<p>New York Amsterdam News, 286</p>
<p>New York Times, 24, 26–27, 105, 117, 119–20, 180–81, 183, 319, 327,
455</p>
<p>Neyman, Jerzy, 197–98</p>
<p>nicotine:</p>
<p>addictive properties of, 270–71</p>
<p>see also cigarettes; smoking; tobacco; tobacco industry</p>
<p>Nisbet, Robert, 193</p>
<p>nitrogen mustard, 207, 220, 257</p>
<p>bone marrow affected by, 88, 90</p>
<p>DNA damaged by, 163, 406</p>
<p>hyperplasia as halted by, 163, 406</p>
<p>as mustard gas, 87–88, 89–90, 162–63</p>
<p>nitrosoguanidine derivatives, 278</p>
<p>Nixon, Richard M., 180–81, 183, 184, 187–88</p>
<p>Nobel Prize, 28, 87, 91, 176, 348, 363</p>
<p>Norris Center, 323</p>
<p>Norton, Larry, 327, 426</p>
<p>Novartis, 436, 439</p>
<p>Nowell, Peter, 365</p>
<p>NSABP-04 trial, 200–201, 203, 220</p>
<p>Nuland, Sherwin, 38</p>
<p>Ochsner, Alton, 256–57</p>
<p>Oedipus the King (Sophocles), 321</p>
<p>Office of Scientific Research and Development (OSRD), 90, 119</p>
<p>Oliver Twist (Dickens), 239</p>
<p>oncogenes, 363, 366, 370–71, 380, 384, 402, 409–11, 412, 415, 431,
439, 443, 450, 453, 454, 462, 466</p>
<p>amplification of, 416</p>
<p>pathological hyperplasia induced by, 357–59, 372, 431</p>
<p>proto-, see proto-oncogenes</p>
<p>see also specific genes</p>
<p>oncology, oncologists, 304, 433</p>
<p>AIDS and, 316–17</p>
<p>death and, 4, 306–8, 337–38</p>
<p>fellowships in, 2–5, 168</p>
<p>origin of term, 47</p>
<p>overconfidence of, 223, 226, 231–32, 234, 308, 310</p>
<p>palliative care and, 224–26, 307</p>
<p>patients’ relationships with, 199, 202, 209, 306–8, 449</p>
<p>radiation, see radiation therapy</p>
<p>OncoMouse, 382–83, 384</p>
<p>onkos, 47</p>
<p>etymology of, 466–67</p>
<p>“On Some Morbid Appearances of the Absorbent Glands and Spleen”
(Hodgkin), 157</p>
<p>opiates, 226</p>
<p>Oregon Health and Science University (OHSU), 434</p>
<p>Orman, Ben, 151–53, 155, 399–400</p>
<p>Osler, William, 45</p>
<p>osteosarcomas (bone tumors), 43</p>
<p>ovarian cancer, 59, 162, 346, 381, 450, 451, 457</p>
<p>ovaries, removal of, 214, 215</p>
<p>Pacific yew tree, 206</p>
<p>Pack, George, 70–71</p>
<p>Padhy, Lakshmi Charon, 410–11</p>
<p>Page, Irvine, 187</p>
<p>paleopathology, 42</p>
<p>palliative care, 223–26, 231, 307</p>
<p>drug trials for, 226</p>
<p>pancreas, 154, 414</p>
<p>pancreatic cancer, 154, 158, 450, 451, 465</p>
<p>Panel of Consultants, 184, 188</p>
<p>Panzer, Fred, 270</p>
<p>Papanicolaou, George, 286–90, 291, 384–85, 386, 401</p>
<p>Papanicolaou, Maria, 287</p>
<p>papillomavirus, 174, 349n, 381n</p>
<p>Pap smears, 228, 286, 287–90, 296, 303, 331, 381, 385, 401</p>
<p>Paré, Ambroise, 49</p>
<p>Paris, University of, 51</p>
<p>Park, Roswell, 24, 45</p>
<p>Parliament cigarettes, 269</p>
<p>Pasteur, Louis, 57</p>
<p>pathology, pathologists, 11–12, 14</p>
<p>Hodgkin’s approach to, 156–57</p>
<p>Patterson, James, 183</p>
<p>PCP (Pneumocystis carinii), 165, 315–16</p>
<p>Pearson, Egon, 197–98</p>
<p>pectoralis major, 64–65</p>
<p>pectoralis minor, 64</p>
<p>pellagra, 110</p>
<p>penicillin, 21–22, 122, 129, 465–66</p>
<p>Penicillium, 122</p>
<p>Pepper, Claude, 26n</p>
<p>peptic ulcers, 281–84</p>
<p>Perkin, William, 81–82, 83</p>
<p>pernicious anemia, 27–28, 31</p>
<p>Peru, 42–43</p>
<p>pesticides, 456–57</p>
<p>Peters, Vera, 159–60</p>
<p>Peters, William, 311–15, 319–20, 321, 325, 326, 329</p>
<p>Peto, Richard, 241, 249, 273–74, 462</p>
<p>pharmaceutical industry, 426</p>
<p>see also specific companies</p>
<p>Philadelphia chromosome, 365, 430–31</p>
<p>Philip Morris, 251, 269–71, 273</p>
<p>phlegm, 48</p>
<p>phosphorylation, 358–59, 361, 380, 418, 431–32</p>
<p>Piccolo, Brian, 181</p>
<p>Pim, Isabella, 58</p>
<p>Pinkel, Donald, 123, 167–68, 170, 178</p>
<p>pitchblende, 74</p>
<p>pituitary cells, 414</p>
<p>placebos, in randomized trials, 131–32, 319</p>
<p>placenta, 135, 219</p>
<p>platelets, 18</p>
<p>Plato, 370</p>
<p>Pneumocystis carinii (PCP), 165, 315–16</p>
<p>pneumonectomy, 242</p>
<p>pneumonia, 45</p>
<p>PCP, 165, 315–16</p>
<p>Poet Physicians, 60</p>
<p>polio, 22, 229, 342, 466</p>
<p>national campaign against, 93–94, 175</p>
<p>Popper, Karl, 370</p>
<p>population, U.S., aging of, 230</p>
<p>Postmortem Examination, The (Farber), 19</p>
<p>Pott, Percivall, 173, 237–39, 241, 276, 447</p>
<p>precancer, 286, 306, 455</p>
<p>Auerbach’s research on, 258–59, 284, 289</p>
<p>prednisone, 127, 140, 143, 149</p>
<p>see also VAMP regimen</p>
<p>Premarin, 213</p>
<p>preventive medicine, 281</p>
<p>epidemiology and, 290</p>
<p>see also cancer prevention</p>
<p>procarbazine, 162, 164</p>
<p>product-liability lawsuits, 269–73, 401</p>
<p>progesterone, 456</p>
<p>“Progress Against Cancer?” (Bailar and Smith), 229, 231–32,
329–30</p>
<p>Prohibition, 262</p>
<p>promyelocytes, 407–8, 409</p>
<p>prostate, 211–13, 215</p>
<p>prostate cancer, 211, 443</p>
<p>in dogs, 212–13</p>
<p>hormonal therapy for, 213–14, 222</p>
<p>remissions in, 214</p>
<p>surgical removal of, 59, 71, 216</p>
<p>prostatectomy, radical, 71</p>
<p>prostatic fluid, 211–12</p>
<p>protein drugs, 414</p>
<p>proteins, 345–46, 442</p>
<p>as molecular switches, 387</p>
<p>phosphorylation of, 358–59, 361, 380, 418, 431–32</p>
<p>signaling pathways of, 387, 388, 389, 402, 406, 432, 443, 453–54,
457, 458, 464–65</p>
<p>structural view of, 432</p>
<p>protocols (clinical trials):</p>
<p>for ABMT, 325–26</p>
<p>for breast cancer, 200–201, 294–302, 420–22, 423, 424, 426–29</p>
<p>for choriocarcinoma, 135–38, 139</p>
<p>conflicts of interest in, 198</p>
<p>for, CML, 436–38</p>
<p>for Hodgkin’s lymphoma, 163–66, 208</p>
<p>for leukemia, 132–34, 135, 139, 140–42, 143–50</p>
<p>of mammography, 294–302</p>
<p>multi-institutional, 207–8</p>
<p>for palliative care, 226</p>
<p>randomization in, 131–32, 160, 243, 293, 298–300, 302, 314, 319, 321,
426</p>
<p>proto-oncogenes, 361–63, 364, 369, 370, 380, 384, 412</p>
<p>activation of, 386–87, 388, 406, 407</p>
<p>pteroylaspartic acid (PAA), 33</p>
<p>public health and hygiene, 22</p>
<p>Public Health Service, U.S., 257, 259, 260</p>
<p>purines, 92</p>
<p>pus, 13, 14</p>
<p>radiation, 74–75</p>
<p>as carcinogen, 75, 77–78, 347, 364, 389</p>
<p>radiation therapy, 23, 154, 158–59, 405</p>
<p>for breast cancer, 75–76, 77, 158, 161, 195, 464</p>
<p>chemotherapy in combination with, 123–24, 154, 168–70, 400</p>
<p>extended field, 159–61</p>
<p>for Hodgkin’s lymphoma, 159–61, 163</p>
<p>involved field, 160</p>
<p>local surgery combined with, 195–96, 197, 464</p>
<p>for lung cancer, 158, 403</p>
<p>for lymphomas, 77, 158</p>
<p>radium in, 76, 195</p>
<p>staging and, 160–61</p>
<p>X-rays in, 75–76, 158–59</p>
<p>radical surgery, 6, 59, 60, 304, 308, 406</p>
<p>see also mastectomies, radical</p>
<p>radio, see broadcast media</p>
<p>radium:</p>
<p>discovery of, 74–75, 76</p>
<p>radiation poisoning from, 74–75, 77–78, 173, 347</p>
<p>in radiation therapy, 76, 195</p>
<p>Radium girls, 78, 278</p>
<p>Ramazzini, Bernardino, 238</p>
<p>Ramses V, King of Egypt, 41</p>
<p>randomization of trials and studies, 131–32, 160, 243, 247, 293, 294,
302, 314, 319, 321, 426</p>
<p>ras gene, 374–75, 376, 379–80, 383, 384, 385, 387, 388, 391, 410,
412, 431n, 453–54, 458</p>
<p>Ras-Mek-Erk pathway, 387, 453–54</p>
<p>Rauscher, Frank, 191, 223, 234</p>
<p>Rb gene, 364, 367–69, 376, 377–80, 381, 391, 412, 453–54, 458</p>
<p>Reader’s Digest, 112</p>
<p>recall bias, 446</p>
<p>receptors, 31</p>
<p>in estrogen, 215, 216, 217, 464</p>
<p>recombinant DNA, 413, 414</p>
<p>red blood cells, 3, 18, 88</p>
<p>Red Queen syndrome, cancer and, 443, 444, 446, 470</p>
<p>Reed, Carla, 1–3, 7, 17–18, 126–27, 168–69, 190, 337, 338–39, 398,
400, 448–49, 459</p>
<p>Reimann, Stanley, 121–22</p>
<p>relapses, 59, 138, 443</p>
<p>of breast cancer, 64, 66–69, 197, 208, 221, 329, 419</p>
<p>of leukemia, 35, 91, 132, 133, 147, 165, 166, 170, 442</p>
<p>remissions:</p>
<p>of ALL, 127, 190, 338–39, 400</p>
<p>of APL, 409–10</p>
<p>of breast cancer, 217, 222, 314, 454, 456</p>
<p>of Hodgkin’s lymphoma, 160–61, 171, 179</p>
<p>of leukemia, 34, 35, 101, 127, 133, 145–46, 179, 190</p>
<p>of, CML, 437–39, 441, 443, 444</p>
<p>retinoblastoma, 366–68, 376, 377, 380, 391</p>
<p>retinoic acid, 408–9</p>
<p>retroviruses, 318, 352, 353, 354, 360, 361–62, 363, 380</p>
<p>as carcinogens, 354, 355–56, 357, 415, 431n</p>
<p>reverse transcriptase, 352–54, 371</p>
<p>Revlimid, 443</p>
<p>Rhoads, Cornelius “Dusty,” 92, 114</p>
<p>Richards, A. N., 121</p>
<p>Richardson, Dora, 216</p>
<p>Rieff, David, 306</p>
<p>risk factors, for disease, 444–45</p>
<p>for cancer, 44, 276, 303, 445–46, 455–57</p>
<p>in social networks, 445–46</p>
<p>risky prediction, 370</p>
<p>R. J. Reynolds, 273</p>
<p>RNA (ribonucleic acid), 91, 345–46</p>
<p>reverse transcription to DNA of, 352–54, 371</p>
<p>transcription from DNA to, 352</p>
<p>viral, 352–54</p>
<p>Roe v. Wade, 199</p>
<p>Rogers, Paul, 187–88</p>
<p>Rollin, Betty, 200</p>
<p>Rome, ancient, medical knowledge in, 48–49</p>
<p>Romeo and Juliet (Shakespeare), 89</p>
<p>Röntgen, Anna, 73</p>
<p>Röntgen, Wilhelm, 73–74</p>
<p>Roosevelt, Franklin D., 25, 94, 404</p>
<p>Rosenberg, Barnett, 204</p>
<p>Rosenberg, C. E., 46</p>
<p>Rosenow, Fanny, 26–27</p>
<p>Rosensohn, Etta, 286</p>
<p>Roswell Park Cancer Institute, 133, 167n</p>
<p>Rous, Peyton, 173, 174, 175, 176, 335, 342–43, 350, 355, 362, 382,
383</p>
<p>Rous sarcoma virus (RSV), 174, 342, 349–50, 351, 358–59, 372, 466</p>
<p>genome as modified by, 351–52</p>
<p>as mutated src gene, 361–62</p>
<p>as retrovirus, 353</p>
<p>Rowley, Janet, 365–66, 376, 409–10, 430–31</p>
<p>Rubin, Harry, 351</p>
<p>Ruijin Hospital, 408, 409–10</p>
<p>Sabin, Albert, 22, 94</p>
<p>St. Bartholomew’s Hospital, 195</p>
<p>St. Christopher’s hospice, 225</p>
<p>St. Jude’s hospital, 167–68, 170</p>
<p>Saint Louis Hospital (Paris), 408</p>
<p>St. Luke’s Hospital, 64</p>
<p>St. Thomas’ Hospital, 156, 157</p>
<p>Salecl, Renata, 182</p>
<p>Salk, Jonas, 22, 94</p>
<p>Salmonella, 277, 278</p>
<p>Salomon, Albert, 290</p>
<p>Salvarsan (compound 606), 86</p>
<p>Samuel, Book of, 305</p>
<p>Sandler, Elliott, 33, 34</p>
<p>Sandler, Robert, 32–34, 35</p>
<p>San Francisco, Calif., AIDS in, 317–18</p>
<p>San Francisco General Hospital, Ward 5B at, 317–18, 424</p>
<p>sarcomas, 173, 174, 443, 467</p>
<p>SARS, 182</p>
<p>Saunders, Cecily, 225–26</p>
<p>Sawyers, Charles, 436, 437, 438, 441–42</p>
<p>Schabel, Frank, 312</p>
<p>Scheele, Leonard, 235</p>
<p>Schleiden, Matthias, 15</p>
<p>Schmidt, Benno, 184–85, 187</p>
<p>Schope, Richard, 174</p>
<p>Schuman, Leonard, 261</p>
<p>Schwann, Theodor, 15</p>
<p>science:</p>
<p>Apollo program and public perception of, 179</p>
<p>goal-driven vs. basic research in, 119–22, 183</p>
<p>measurement in, 19, 74, 197–98, 227</p>
<p>technology vs., 462</p>
<p>Science the Endless Frontier (Bush), 120</p>
<p>Scientific American, 227–28, 350</p>
<p>scientific revolutions, 196</p>
<p>screening:</p>
<p>for breast cancer, 457, 464; see also mammography</p>
<p>colonoscopy, 331, 401</p>
<p>molecular biology and, 457–58</p>
<p>over- vs. underdiagnosis in, 291–92, 293, 302</p>
<p>Pap smears, 288–90, 296, 303, 331, 401</p>
<p>as prone to error, 302</p>
<p>scrofula, 47</p>
<p>scrotal cancer, 173, 237–39, 241, 276</p>
<p>scurvy, 110</p>
<p>sea urchins, 341, 348, 349</p>
<p>secondhand smoke, 260</p>
<p>Senate, U.S., 122, 185</p>
<p>see also Congress, U.S.</p>
<p>Shakespeare, William, 1, 89, 191</p>
<p>Shapiro, Sam, 294–95, 296, 297, 299, 302</p>
<p>Shelby County, Tenn., 289–90</p>
<p>Shepard, Mike, 418, 420, 427</p>
<p>Sheridan, Catherine Variety, 95, 96</p>
<p>Shih, Chiaho, 373–74, 376</p>
<p>Shimkin, Michael, 107</p>
<p>Shinder, Jason, 398</p>
<p>signaling pathways, 387, 388, 389, 402, 406, 432, 443, 453–54, 457,
458, 464–65</p>
<p>Silent Spring (Carson), 456</p>
<p>6-mp (6-mercaptopurine), 92, 127, 132–33, 140, 143, 338</p>
<p>see also VAMP regimen</p>
<p>Skipper, Howard, 139, 140–41, 143, 196, 206, 311–12</p>
<p>Skolnick, Mark, 381</p>
<p>Slamon, Dennis, 415–19, 433</p>
<p>Herceptin trials of, 420–22, 423, 426–29</p>
<p>sleeping sickness, 85, 245</p>
<p>slime molds, 345, 346, 349</p>
<p>smallpox, 24, 41, 175, 225, 343</p>
<p>Smith, Anna Deavere, 305</p>
<p>Smith, Edwin, 39</p>
<p>Smith, Elaine, 229, 231–34</p>
<p>Smith papyrus, 39–41</p>
<p>smoking, 45, 250, 251, 267–68, 272, 273–74, 275, 445–46</p>
<p>cancer and, see tobacco-cancer link</p>
<p>decrease in, 401</p>
<p>increase in, 240–42, 445</p>
<p>social networks and, 445–46</p>
<p>by women, 268, 445</p>
<p>see also cigarettes; nicotine; tobacco; tobacco industry</p>
<p>Smoking and Cancer (Graham), 257</p>
<p>“Smoking and Carcinoma of the Lung” (Doll and Hill), 246</p>
<p>snuff, 239–40</p>
<p>social networks, as risk factors for disease, 445–46</p>
<p>Solzhenitsyn, Aleksandr, 4, 181, 316, 461</p>
<p>Sontag, Susan, vii, 37–38, 202, 306, 316, 388, 449</p>
<p>soot, 173, 238, 239, 364</p>
<p>Sophocles, 321</p>
<p>Sorenson, Beatrice, 153–55</p>
<p>Special Virus Cancer Program, 175–76, 280–81, 356, 357</p>
<p>specificity, specific affinity, 80–81, 84–88, 90–92, 210, 222, 432,
433, 434, 439</p>
<p>Spector, Deborah, 361</p>
<p>Speyer, Maria, 17</p>
<p>Spiegelman, Sol, 186, 355–56, 357, 360, 362</p>
<p>spinal fluid:</p>
<p>chemotherapy and, 167–68</p>
<p>leukemia in, 146–47</p>
<p>spinal taps, 127, 146</p>
<p>spleen, leukemia and, 14</p>
<p>src gene, 375, 418, 431, 433</p>
<p>endogenous, 361–62, 364, 368, 371, 466</p>
<p>viral, 358–60, 364, 368, 370, 372</p>
<p>stages, staging, of cancers, 55, 67, 160–61, 163, 164–65, 218, 222,
289, 290, 385, 428, 463</p>
<p>STAMP (Solid Tumor Autologous Marrow Program) protocol, 310, 311–15,
320, 325, 326, 328–29</p>
<p>as adjuvant therapy, 320</p>
<p>Statistical Unit, 245</p>
<p>statistics:</p>
<p>negative claims in, 197–98</p>
<p>normalization in, 230–31; see also age-adjusting</p>
<p>staurosporine, 432</p>
<p>Stehelin, Dominique, 361</p>
<p>Stein, Gertrude, 227</p>
<p>stem cells, 398, 458</p>
<p>sterility, as side effect of chemotherapy, 165</p>
<p>Sternberg, Carl, 157</p>
<p>steroids, 103</p>
<p>stomach cancer, 44–45, 381, 456</p>
<p>neurotic stress blamed for, 281</p>
<p>Strax, Philip, 294–95, 296, 297, 299</p>
<p>streptomycin, 22, 131–32</p>
<p>stroke, 444</p>
<p>Study in Scarlet, A (Doyle), 9</p>
<p>SU11248, 468</p>
<p>Subbarao, Yellapragada “Yella,” 30–31, 33, 34, 35, 87, 91</p>
<p>sulfa drugs, 110</p>
<p>Sun Tzu, 210</p>
<p>Supreme Court, U.S., 266</p>
<p>surgeon general, U.S., 259–60</p>
<p>smoking-health report of, 260–62, 264, 267, 401</p>
<p>surgeons:</p>
<p>as hostile to chemotherapy, 219–21</p>
<p>self-confidence of, 66, 308</p>
<p>surgery, 355, 405</p>
<p>abdominal, 58</p>
<p>for breast cancer, 58, 62, 195–96, 197, 201, 402; see also
mastectomies</p>
<p>evolution of, 55, 61–62, 66</p>
<p>infection as risk of, 56–57</p>
<p>local, combined with radiation therapy, 195–96, 197, 464</p>
<p>for lung cancer, 59, 72, 256</p>
<p>as performance, 66</p>
<p>radical, see mastectomies, radical; radical surgery</p>
<p>removal of tumors through, 41, 49–50, 55, 58–59</p>
<p>survival rates, bias in, 229–30</p>
<p>SV 40, 349n</p>
<p>Sweden:</p>
<p>ABMT trial in, 326</p>
<p>mammography trials in, 298, 300–301</p>
<p>Swinburne, Algernon Charles, 461</p>
<p>Sylvester, Robert, 34</p>
<p>Symington, Stuart, 186</p>
<p>syphilis, 86, 157, 238</p>
<p>Tabin, Cliff, 383</p>
<p>Taft, William Howard, 24–25</p>
<p>Talman, William, 266–67</p>
<p>Talpaz, Moshe, 436, 437, 438, 441, 442</p>
<p>tamoxifen, 216–17, 218, 221–22, 407, 456, 457, 464, 466</p>
<p>Tarceva, 455</p>
<p>targeted therapies, 405–11, 412, 443, 455</p>
<p>for APL, 407–10</p>
<p>for breast cancer, 413–22, 454, 464, 465</p>
<p>for, CML, 430–40, 441–43</p>
<p>Tatum, Edward, 345</p>
<p>Taxol, 206, 403–4, 427–28</p>
<p>technology, 466</p>
<p>medicine as, 462</p>
<p>television, see broadcast media</p>
<p>Temecula, Calif., 321–22, 324</p>
<p>Temin, Howard, 350–55, 357–58, 359, 361–62, 371, 372</p>
<p>Tenth International Cancer Congress, 353–54</p>
<p>teratoma, 152</p>
<p>Terry, Luther, 259–60, 262–63</p>
<p>testicular cancer, 181, 204–5, 208, 228, 331, 401</p>
<p>testosterone, 212–13, 214, 215</p>
<p>tetracycline, 22</p>
<p>thalidomide, 199, 443</p>
<p>thioguanine, 127</p>
<p>Thomas, E. Donnall, 309, 434</p>
<p>Thomas, Lewis, 430</p>
<p>Thomas Aquinas, Saint, 393</p>
<p>Thoreau, Henry David, 38</p>
<p>Through the Looking-Glass (Carroll), 441, 443</p>
<p>thymoma, 152</p>
<p>thyroid cancer, 152, 212</p>
<p>thyroid hormone, 212</p>
<p>Time, 22, 24, 25, 103, 178</p>
<p>tobacco:</p>
<p>bacterial mutations caused by, 278</p>
<p>British addiction to, 240</p>
<p>oral cancers linked to, 239–40</p>
<p>U.S. production of, 240</p>
<p>see also cigarettes; nicotine; smoking; tobacco industry</p>
<p>tobacco-cancer link, 276, 290, 364, 388</p>
<p>antitobacco campaigns and, 401, 446</p>
<p>author’s encounters with, 274–75</p>
<p>causality dispute in, 253–56</p>
<p>Doll/Hill studies and, 245–49, 250–51, 253–54, 260, 262, 263, 276,
294, 350, 401, 455</p>
<p>J. Hill’s pamphlet on, 239–40, 276</p>
<p>lag time in, 272</p>
<p>as obscured by prevalence of smoking, 241–42</p>
<p>public policy and, 257, 259–62</p>
<p>secondhand smoke and, 260</p>
<p>surgeon general’s report on, 260–62, 264, 267, 401</p>
<p>tobacco industry and, 250–53, 258, 259, 260, 264</p>
<p>Wynder/Graham study and, 244–45, 246–47, 252, 253–55, 256, 260, 263,
401</p>
<p>tobacco industry:</p>
<p>advertising by, 250–51, 263–64, 265–67, 268, 273</p>
<p>developing countries targeted by, 273–74</p>
<p>government regulation of, 262–65, 273</p>
<p>Master Settlement Agreement and, 273</p>
<p>political power of, 259, 260, 264, 273</p>
<p>product-liability lawsuits against, 269–73, 401</p>
<p>public relations campaigns by, 250–53, 258, 266</p>
<p>women targeted by, 268</p>
<p>Tobacco Industry Research Committee (TIRC), 253, 264</p>
<p>Tobacco Research Institute, 270</p>
<p>tobacco tokens, 246</p>
<p>Tocqueville, Alexis de, 107–8</p>
<p>Todaro, George, 358n</p>
<p>tongue cancer, 274</p>
<p>total therapy (chemotherapy plus radiation), 123–24, 154, 168–70</p>
<p>toxicity, of chemotherapy, 43–44, 168, 208, 305, 309, 320</p>
<p>traits, heritability of, 343–44, 364, 366</p>
<p>transfusions, 196, 280</p>
<p>transgenic mice, 382–83, 384</p>
<p>trans-retinoic acid, 408–10</p>
<p>Trastuzumab, see Herceptin</p>
<p>Traut, Herbert, 288</p>
<p>Treponema pallidum, 86</p>
<p>Tripathy, Debu, 424</p>
<p>True cigarettes, 269</p>
<p>Truman, Harry, 117, 120</p>
<p>Truth or Consequences, 97–99</p>
<p>Trypanosoma gondii, 85</p>
<p>Trypan Red, 85</p>
<p>tuberculosis, 24, 41, 72, 84, 87, 157, 175, 256</p>
<p>in ancient world, 44</p>
<p>as iconic 19th century disease, 37–38, 45</p>
<p>mortality rates from, 229</p>
<p>naming of, 47</p>
<p>public hygiene and, 22</p>
<p>streptomycin and, 131–32</p>
<p>tumors, 16, 19</p>
<p>angiogenesis of, 387, 388, 389, 391, 407, 443, 458</p>
<p>Baillie’s descriptions of, 53–54</p>
<p>bone, 43</p>
<p>brain, 71–72</p>
<p>chemotherapy for, 122–23, 154, 207, 308–9</p>
<p>in Galenic theory, 48–49</p>
<p>malignant vs. benign, 47, 56</p>
<p>metastasis of, 55, 67, 135, 136, 154, 195–96, 302–3, 389</p>
<p>premetastatic, 302–3</p>
<p>radiation therapy for, 76, 77, 154, 158–59</p>
<p>stages of, 55, 67, 160–61, 218</p>
<p>surgical removal of, 41, 49–50, 55, 58–59</p>
<p>see also specific cancers</p>
<p>tumor suppressor genes, 368–69, 376, 380, 381, 384, 385, 402, 412,
450, 453</p>
<p>inactivation of, 386–87, 389, 391, 406, 407</p>
<p>Turner, Charlotte, 325</p>
<p>two-hit hypothesis, 367–69, 376, 377, 380</p>
<p>typhoid fever, 22, 24</p>
<p>typhus, 41, 46</p>
<p>Uganda, 204n</p>
<p>Ullrich, Axel, 414–18, 420, 427, 433</p>
<p>umbilical blood, 398–99</p>
<p>Undark, 77</p>
<p>United Kingdom, see Great Britain</p>
<p>uranium, 74</p>
<p>Urban, Jerome, 193, 198</p>
<p>urea, 83, 84</p>
<p>urological cancers, 71</p>
<p>U.S. Radium, 77–78</p>
<p>uterine cancer, 59, 277, 306, 331</p>
<p>Uzbekistan, cigarette consumption in, 274</p>
<p>vaginal cancer, 277</p>
<p>VAMP regimen, 142, 143–50, 165, 310</p>
<p>consortium opposition to, 144</p>
<p>relapses and, 166</p>
<p>remissions and, 145–46</p>
<p>survivors of, 148–50</p>
<p>Zubrod’s opposition to, 143</p>
<p>Variety Club of New England, 95, 172</p>
<p>Varmus, Harold, 360–63, 364, 365, 369, 370, 371, 375, 380, 439</p>
<p>vectors, for infectious diseases, 245</p>
<p>Velcade (bortezomib), 443</p>
<p>Venet, Louis, 294–95, 296</p>
<p>Verghese, Abraham, 308</p>
<p>Veronesi, Umberto, 220</p>
<p>Vesalius, Andreas, 51–53, 54, 59, 211, 434, 455</p>
<p>Vietnam War, 187, 207</p>
<p>vinblastine, 205</p>
<p>vincristine (Oncovin), 127, 139–40, 143, 149, 162, 164, 406</p>
<p>see also VAMP regimen</p>
<p>Virchow, Rudolf, 13–16, 18, 237, 340, 430, 431, 455</p>
<p>Virginia, tobacco production in, 240</p>
<p>Virginia Slims cigarettes, 267, 268–69</p>
<p>virology, virologists, 349–56, 357–62, 364, 371, 466</p>
<p>viruses:</p>
<p>as carcinogens, 173, 174–76, 278–81, 303, 342–43, 349–50, 351–56,
362</p>
<p>RNA forms of, see retroviruses</p>
<p>Visco, Frances, 426, 427, 429</p>
<p>vitalism, 83</p>
<p>vitamin B12, 28, 31</p>
<p>Vogelstein, Bert, 384–86, 448</p>
<p>Cancer Genome Atlas and, 450–54</p>
<p>Vogt, Peter, 358</p>
<p>Volberding, Paul, 317, 424</p>
<p>Volkmann, Richard von, 62, 64, 67</p>
<p>Voltaire, 143</p>
<p>von Hansemann, David Paul, 340–41, 366</p>
<p>Waksman, Selman, 122</p>
<p>Wall Street Journal, 181</p>
<p>Walpole, Arthur, 216, 304</p>
<p>Walters, Barbara, 186</p>
<p>Wang, Zhen Yi, 408–1</p>
<p>war gasses, 87–88, 89–90</p>
<p>Warm Springs Foundation, 94</p>
<p>War on Cancer, 121, 172–73, 313, 329, 330, 332, 350, 455</p>
<p>Apollo space program as analogous to, 178–79</p>
<p>defining success in, 461–63, 465</p>
<p>Farber and, 114, 118, 122, 150, 155, 178, 180, 184, 188, 190, 234</p>
<p>measuring progress in, 227, 231, 323–33</p>
<p>M. Lasker and, 113–14, 117–18, 122, 155, 177–78, 179, 183–86, 188–89,
191, 234, 296, 402, 403</p>
<p>Nixon and, 180–81, 184, 187–88</p>
<p>Panel of Consultants in, 184, 188</p>
<p>Times ad in, 180–81, 183</p>
<p>Warren, Robin, 281–84, 456</p>
<p>Washington Post, 32, 73, 180–81</p>
<p>Watson, James, 89, 186–87, 393, 455</p>
<p>Weinberg, Robert, 355, 370–76, 379–80, 390–92, 410–11, 412, 413,
443</p>
<p>Weissman, George, 262</p>
<p>Welch, William, 63</p>
<p>Western General Hospital, 329</p>
<p>white blood cells (lymphocytes), 3, 13, 17, 29, 152, 407, 409</p>
<p>aminopterin and, 33–34</p>
<p>chemotherapy and, 127, 315</p>
<p>nitrogen mustard and, 88, 90</p>
<p>in response to infection, 13, 16</p>
<p>Whitehead Institute, 376–77, 379</p>
<p>Wiedrich, Bob, 187</p>
<p>Wigler, Michael, 374, 376</p>
<p>Williams, Ted, 102</p>
<p>Williams, William Carlos, 306</p>
<p>Wills, Lucy, 28, 29</p>
<p>Wilms’ tumor, 123–24</p>
<p>Wit (Edson), 205, 209</p>
<p>Witwatersrand, University of, 321, 323, 326, 327–28</p>
<p>Woglom, William, 80</p>
<p>Wöhler, Friedrich, 83–84</p>
<p>Wolfe, Thomas, 93</p>
<p>Wolff, James, 34</p>
<p>Wolfler, Anton, 62</p>
<p>women:</p>
<p>cigarette advertising targeted to, 268</p>
<p>lung cancer mortality rate in, 331</p>
<p>smoking by, 268, 445</p>
<p>Women’s Field Army, 111, 113</p>
<p>Wood, Francis Carter, 46</p>
<p>Woodard, Frank, 108</p>
<p>Woodard, Sara Johnson, 108, 109–10</p>
<p>Worcester Foundation, 217</p>
<p>World War I:</p>
<p>cigarette consumption increased by, 250</p>
<p>mustard gas in, 87–88</p>
<p>World War II, 26, 89, 109, 129</p>
<p>cigarette consumption increased by, 250</p>
<p>scientific research in, 119–20, 129–30</p>
<p>Wynder, Ernst, 250</p>
<p>tobacco-cancer study of, 244–45, 246–47, 252, 253–55, 256, 260, 263,
401</p>
<p>X-rays, 23, 44</p>
<p>as carcinogen, 77–78, 347, 349, 389</p>
<p>as diagnostic tool, 291; see also mammography</p>
<p>discovery of, 73–74</p>
<p>DNA damaged by, 75, 77</p>
<p>mutation increased by, 278, 347</p>
<p>in radiation therapy, 75–76, 123–24, 127, 158–59</p>
<p>Yale–New Haven Hospital, 226</p>
<p>Yarborough, Ralph, 184</p>
<p>yellow bile, 48, 53</p>
<p>Young, Hugh Hampton, 71</p>
<p>Ypres, Belgium, 88</p>
<p>Ziegler, John, 207</p>
<p>Zimmermann, Jürg, 433, 435</p>
<p>Zubrod, Gordon, 129–30, 132, 134, 137–38, 139, 140, 147, 162, 163–64,
207, 260</p>
<p>leukemia research consortium created by, 130–31, 133</p>
<p>VAMP opposed by, 143</p>
<h6 id="阅读日期-2026年02月15日-2026年02月15日-共-1-天">阅读日期：
2026年02月15日-2026年02月15日 共： 1 天</h6>
<script src="https://giscus.app/client.js"
        data-repo="hbaolong/hbaolong.github.io"
        data-repo-id="R_kgDOLetDQg"
        data-category="General"
        data-category-id="DIC_kwDOLetDQs4CfLEl"
        data-mapping="url"
        data-strict="0"
        data-reactions-enabled="1"
        data-emit-metadata="1"
        data-input-position="top"
        data-theme="preferred_color_scheme"
        data-lang="zh-CN"
        crossorigin="anonymous"
        async>
</script>
</body>
</html>
